Effects of different estrus synchronization and superovulation treatments on ovarian response and embryo collection in the South African Boer goat by Mpoyo, Robert Kabyla
EFFECTS OF DIFFERENT ESTRUS SYNCHRONIZATION AND
SUPEROVULATION TREATMENTS ON OVARIAN RESPONSE
AND EMBRYO COLLECTION IN THE SOUTH AFRICAN
BOER GOAT
DR. ROBERT KABYLA MPOYO
Thesis presented in partial fulfillment of the requirements for the degree of
MASTER OF SCIENCE AGRIC
at the University of Stellenbosch
Supervisor:
Dr Daniel Malan Bany
April,2004
DECLARATION
I, the undersigned, hereby declare that the work contained in this thesis is my own
original work and that I have not previously in its entirety or inpart submitted it at
any university for a degree.
Stellenbosch University http://scholar.sun.ac.za
ABSTRACT
Different synchronization and superovulation treatments were evaluated in the South African Boer
goat (n = 367). Two progestagen implants, Synchro-Mate-B (SMB)/Crestar™ and Controlled
Internal Drug Releases (CIDR), containing 3mg norgestomet and 0.33gm of natural progesterone,
respectively, were used in the synchronization treatments. A luteolytic agent, Estrumate
(Cloprostenol) 125)lg, was administered 12h before progestagen withdrawal. Synchronization
treatment groups were: 1) 5MB x 1 (n = 123), one dose of 5MB for 13 to 17 days; 2) 5MB x 2 (n =
32), two doses of 5MB implanted for 10then 17 days; 3) CIDR x 1 (n = 187), one dose of CIDR;
4) CIDR x 2 (n = 25), two doses of CIDR, inserted for 9 to 17 days. On day 1 of the treatment,
0.5mg of estradiol cypionate (ECP) was administered to a group of randomly chosen goats (n =
112). Superovulation treatments consisted of Ovagen ™ or Embryo-STM. An additional single dose
(300 UI) of Pregnant Mare Serum Gonadotropin (PMSG) was administered to a group of randomly
chosen does. Superovulation treatment groups were: 1) OV alone (n = 147), Ovagen 9 mg every
12h, 8 times starting 72h prior to progestagen removal; 2) OV + PMSG (n = 164), same treatment
as 1 plus 300 ru ofPMSG once 48h prior to progestagen removal; 3) E-S alone (n=16), Embryo-S
25 units twice a day, 8 times starting 72h before progestagen removal; 4) E-S + PMSG (n=40),
same treatment as 3 plus 300 ru of PMSG once 48h prior to progestagen removal. Most does were
naturally bred to bucks. Embryos were collected using the surgicallaparascopic procedure on day
6 and corpora lutea counted. Data were not normally distributed and therefore analyzed using a
nonparametrie test (Wilcoxon, 1945 and Kruskal- Wallis, 1952) with outcome variable using the
Mixed Procedure of SAS and the Tukey test. Differences were considered significant at p<0.05.
Slightly more CL were on the left (52%) than on the right (48%) ovary. Superovulation treatment
was significantly associated (p<O.OOl) while synchronization treatment was only marginally
associated (p=0.06) with ovulation rate. Ovagen alone and Ovagen + PMSG were significantly
more effective (p<0.05) than Embryo-S alone or Embryo-S + PMSG in influencing ovulation.
Only synchronization treatment with 2 doses of CIDR was significantly more (p=0.04) effective in
producing a high ovulation rate. Superovulation treatment was significantly (p=0.02) associated
with the number of transferable embryos while synchronization treatment was not. Ovagen +
PMSG was significantly (p=0.02) effective in producing more transferable embryos than Embryo-S
+ PMSG. Both superovulation and synchronization treatments were significantly (p<0.05)
associated with producing unfertilized oocytes. Effectiveness of addition of ECP was shown in its
association (p=0.05) with better quality embryos in univaraete analysis, though it did not have
significant effect in the multivariate model. Though there was apparent advantage of CIDR over
5MB, no significant difference in ovulation rate or embryo quality was associated with
synchronization treatments. Effectiveness of Ovagen over Embryo-S was demonstrated and
addition ofPMSG improved embryo quality.
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OPSOMMING
Verskillende sinkronisasie en multi-ovulasie behandelings is ge-evalueer in die Suid-Afrikaans Boerbok (n=
367). Twee progestagene, Synchro-Mate-B (SMB)/Crestar™ en Controlled Internal Drug Releases (CIDR),
bevattende 3mg norgestomet en 0.33gm natuurlike progesteroon, respektiewelik, is gebruik tydens die
sinkronisasiebehandelings. 'n Luteolitiese middel, Estrumate (Cloprostenol) 125J.lg, is toegedien 12 h voor
progestageen verwydering. Sinkronisasie behandelings groepe was: 1) 5MB x 1 (n = 123), een dosis 5MB
vir 13 tot 17 dae; 2) 5MB x 2 (n = 32), twee dosisse 5MB implante vir 10 tot 17 dae; 3) CIDR x 1 (n = 187),
een CIDR vir die hele periode; 4) CIDR x 2 (n = 25), twee CIDRs, vir 9 tot 17 dae. Op dag 1 van die
behandeling is 0.5mg estradiol cypionate (ECP) aan 'n willekeurige groep bokooie toegedien (n = 112).
Multi-ovulasie behandelings het bestaan uit Ovagen™ of Embryo-S™. 'n Bykomstige dosis (300 UI)
Dragtige Merrie Serum Gonadotrofien (PMSG) is toegedien aan 'n willekeurige groep ooie. Multi-ovulasie
behandelingsgroepe was: 1) OV alleen (n = 147), Ovagen 9 mg elke 12h, 8 keer beginende 72 h voor
progestageen verwydering; 2) OV + PMSG (n = 164), selfde behandeling as in (1) plus 300 IV PMSG
eenmalig 48h voor progestageen verwydering; 3) E-S alleen (n=16), Embryo-S 25 eenhede tweemaal per
dag, ag inspuitings beginende 72h voor progestageen verwydering; 4) E-S + PMSG (n=40), selfde
behandeling as in (3) plus 300 IV PMSG eenmalig 48h voor progestageen verwydering. Die meerderheid
ooie is natuurlik deur ramme gedek. Embrio's is gekollekteer deur gebruik te maak van die chirurgies-
laparoskopiese metode op dag 6 en die aantal corpora lutea getel en aangeteken. Aangesien die data nie 'n
eweredige verspreiding gehad het nie, is dit geanaliseer deur gebruik te maak van 'n nie-parametriese toets
(Wilcoxon, 1945 en Kruskal-Wallis, 1952) met variërende uitkomste deur die Gemengde Prosedure Toets
van SAS en die Tukey toets. Verskille is as beduidend aanvaar met 'n P-waarde van <0.05. Onbeduidend
meer CLs is op die linker (52%) as op die regter (48%) ovarium opgemerk. Multi-ovuasie behandelings was
beduidend geassosieer (p<0.001) met ovulasietempo, terwyl sinkronisasie behandelings net marginaal
geassosieer was (p=0.06) met ovulasietempo. Ovagen alleen en Ovagen + PMSG was beduidend meer
effektief (p<0.05) as Embryo-S alleen of Embryo-S + PMSG om ovulasie te beïnvloed. Slegs die
sinkronisasie behandeling met 2 dosisse CIDR was beduidend meer (p=0.04) effektief om 'n hoër
ovulasietempo te veroorsaak. Multi-ovulasie behandeling was beduidend geassosieer met die aantal
oordraagbare embrio's, terwyl sinkronisasie nie dieselfde tendens gewys het nie. Ovagen + PMSG het
beduidend meer (p=0.02) oordraagbare embrio's opgelewer as Embryo-S + PMSG. Beide multi-ovulasie en
sinkronisasie behandelings was beduidend geassosieer (p<0.05) met onbevrugte oosiete. Die rol van die
byvoeging van ECP is getoon in die assosiasie daarvan (p=0.05) met beter kwaliteit embrio's in 'n
eenvariante analiese, alhoewel dit nie 'n beduidende effek op die multi-variante model gehad het nie.
Alhoewel dit blyk dat CIDR 'n beter reaksie as 5MB gee, kon geen beduidende verskil in die ovulasietempo
of embriokwaliteit opgewys word nie. Die groter effektiwiteit van Ovagen oor Embryo-S is gedemonstreer,
terwyl die byvoeging van PMSG embriokwaliteit verbeter het..
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CHAPTER 1
INTRODUCTION
1.1 PROBLEM STATEMENT AND MOTIVATION OF THE STUDY
According to the FAO 1978 report, the world population of goats was about 410 million while
that of sheep was around 1028 million. The data of the year 1978 show that the goat population
represented around 15% of the world population of grazing domestic animals, whereas the sheep
to goat ratio was 2.5 during that year (Devendra & Coop., 1982). The goat number went over
470 million in 1982. The 1998 statistics of the world population of grazing domestic animals,
according to the FAO 1998 annual report, was about 162 million buffaloes, 1318 million cattle,
1064 million sheep and 700 million goats. The FAO tables show that the ratio of sheep/goats
has decreased to approximately 1.5 in 10 years. The same data of 1998 show also that,
excluding pigs, compared to the world population of buffaloes, cattle and sheep, the goat
population represents about 19% of the world population of grazing domestic animals. Recent
data are putting the figure at more than 732 million (FAO 2000).
These figures clearly show how the world population of goats has increased steadily over the last
decades, at an annual rate of 2.6%, during the last 20 years. Most of this increase in goat
population has occurred, as we will notice, in those areas of the world where the goat is well
established as an important domestic animal, namely in Africa, Asia and to a lesser extent in
South America. It is most likely that the result of improved production systems and
management, leading to better nutrition and herd health, is responsible for this increase in goat
population number. The goat population in Africa, Asia and South America has grown from
nearly 425 million in 1979, to reach over 667.57 million in 1998. That is about a 12 million
increase per year. InEurope, North and Central America, and Oceania, the goat population grew
from 25 to 32.4 million during the same period, representing an average growth of 0.4 million
goats per year (FAO 1994, 1998).
To illustrate the importance of the goats in the tropics, where most developing countries are
located, the following figures can be mentioned: over 60% of sheep are found in developed
temperate zones (which mostly include industrialized countries) and less than 40% in tropical
zones. The distribution of goats, however, is in sharp contrast to that of sheep. Nearly 80% of
all goats are found within the band 0-40 degrees north, in the arid tropical and subtropical region
1
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(Devendra & Coop, 1982). Strictly speaking, a big portion of South Africa is not part of the
tropical region. However, with the wide variation of the climate, due to many geographical
factors that occur in the tropical zone, some countries immediately outside the tropics, e.g. South
Africa, are included (Devendra & Bums, 1970).
It should be borne in mind, however, that statistics used in goats, especially in developing
countries, although official, may not be very reliable and that populations can vary considerably
according to many factors. Inmy own experience in the Democratic Republic of Congo, small
cattle breeders and goat-keepers were reluctant to give account of their livestock (goats and
cows). They would underestimate the number because of the general tendency to undervalue
property for fear of taxation or other causes. It should also be noticed that a great number of
animals in the tropics are slaughtered outside official slaughterhouses and/or informally
marketed, making the statistics found in the literature somehow biased.
The goat number relative to other livestock shows the importance of goats in the agriculture of
several countries in the tropics. In the Democratic Republic of Congo, for example, there were
four million goats in the 1978 FAO annual report, which is more than any other species of
livestock. In Tanzania, according to the same report, the population of goats was about 2.5
times that of sheep. In India it was twice and in west Malaysia seven times the number of sheep,
(Devendra & Bums, 1970). Paradoxically, South Africa has many times more sheep (30
million) than goats (7 million). In South Africa, the number of goats has fluctuated very little
since 1946. About 70% of that number was owned by the African people, living in traditionally
settled areas (Hugo, 1968). South African statistics (SA official Yearbook, 1998) show,
however, that the indigenous meat producing Boer goats accounts for about 40% of all goats,
and the Angora goats, used for mohair production, form the remaining 60%.
Goats are multi -purpose animals producing meat, milk, skin and hair. While in western
countries goats are mainly kept as dairy animals, their worldwide importance is chiefly as
producers of meat (Gall, 1981). In most Asian countries and in Africa (where dwarf breeds
prevail), goats are considered almost exclusively as meat animals. One advantage of goats as
suppliers of meat is that they produce small carcasses, which can be consumed by a family or a
group of families without need of retailing or preserving. This is considered an advantage in the
tropics in particular. On the other hand, the South African Boer goat (Fig. 1-1 and 1-2), whose
primary function is meat production, is of excellent conformation according to Devendra &
Bums (1970), and probably one of the breeds that exhibit the most pronounced meat production
2
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qualities. For a growing world population, especially encountered in developing countries, the
Boer goat may become both efficient and a more important supplier of high quality and quantity
food, as well as a source of improved genetic material.
The Boer goats are fairly widespread over South Africa, although certain parts are more suitable
for goat farming, e.g. where bushes grow higher and thicker, and rough mountain parts, to which
others livestock species are not so well adapted. For this reason, the Western, Eastern and
Northern Cape Provinces lodge more than half of the Boer goat population of the country
(Greyling, 1988).
When the history of the development of the Boer goat is reviewed, it is apparent that almost
every author has a different view on the subject. Some authors claim that the South African
Boer goat breed was developed from goats imported from Nubia. According to Schreiner
(1898), the Boer goat was developed from goats imported from Europe while Pegler (1886)
stated that the South African Boer goat breed originated from goats brought to South Africa
from India. Some others authors according to Hofmeyr & Meyer (1984), including Barrow,
1801; Epstein, 1971 and Mason, 1981 appear to have the most realistic view in their
descriptions, ascribing the origin of the Boer goat to the goats of Hottentot tribes to which
imported goats from India were crossed (Devendra & Bums, 1970). Whatever the origin of the
Boer goat might be, what remains true is that the present improved Boer goat is the fruit of a
human technological effort of genetic improvement and the demonstration of what can be
achieved if careful genetic selection is practiced. As a result, several qualitative and quantitative
traits such as excellent meat conformation, relative high average mass gains in kids, uniformity
with regard to color (white hair with red head markings), hardiness and adaptability, and high
fertility have been remarkably enhanced.
The motivation for this study resided in the fact that the world human population is growing,
especially in developing countries. Large proportions of the world's livestock are kept in
developing countries (95% of goats and 65% of cattle) under husbandry systems that need to be
improved in order to meet the challenge of food security for the people. This also constitutes a
tremendous gene pool that can contribute to the variation of these two species worldwide. To be
able to achieve and maintain an efficient production of animal protein, a high level of
reproductive performance is crucial. The impact of most recent scientific and technological
advances on production in livestock breeding, especially in developed countries, is beyond
doubt. As a result of implementation of research and improved management, South African
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agricultural production has more than doubled during the last 30 years (SA Yearbook, 1993).
The South Africans have also shown what is possible with respect to selective breeding of meat
goats. Their improved Boer goat is a most impressive animal and quite unlike meat goats in any
other countries (Mow len, 1992). The use of artificial insemination in cattle for commercial
purpose is an illustration of the application of the benefits of the technological advances. The
techniques of multiple ovulation and embryo-transfer have been successfully practiced
commercially for more than 20 years in the cattle industry in developed countries. Considering
advances made in cattle embryo recovery and transfer techniques, during the last decades, can
these technologies benefit goats in tropical countries?
1.2 OBJECTIVEOF THE STUDY
The principal objective of this study was to assess the results of different multi-ovulation
programs used in Boer goats in our different experiments. Variability in ovarian response has
been related to differences in superovulatory treatments such as gonadotropin preparation (FSH
and PMSG), duration of treatment, and timing of treatment with respect to the estrous cycle, the
total dose of gonadotropin, and the use of additional hormones in the superstimulatory scheme.
As most of these above-mentioned factors have been reported in several publications in species
like cows and sheep, the contribution of this study will be found in the application of some of
these superovulatory and synchronization treatments in the Boer goat. This study was also to
explore the impact of additional environmental factors such as season, age, location, and
nutritional status as measured by the body condition score of animals. In exploring the different
superovulatory and synchronization treatments in the South African Boer Goat, this thesis would
contribute particularly to the study of this less reported and described species, the goat. The
development of an embryo industry of goats in South Africa may play an important role in
animal production within the country, in Africa and in many others tropical regions in the world.
This technology may be part of or contribute to the development of the goat industry for
production of the so much needed protein in this part of the world, since protein rather than
energy is often the main deficiency in human nutrition.
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Fig 1-1 Improved Boer goat male
Fig. 1-2 Improved Boer goat female
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CHAPTER2
LOCATIONS OF THE STUDY AND ANIMAL MANAGEMENT
2.1 DESCRIPTION OF THE STUDY AREAS
South Africa's location has had a great influence on many aspects of its geography and
development. Thus its sunny, dry climate and the small variation between summer and winter
daylight periods are attributable to its subtropical latitudinal position (SA Yearbook, 1994). The
present study was carried out in two locations both situated in the former Province of the Cape,
stretching latitudinally from 31 degrees 29 min. to 33 degrees 57 south, and longitudinally from
18 degrees 50 min. to 25 degrees east: the African Embryo & Semen (AES) station in
Stellenbosch (Lat. 33 degrees 57 min, Long. 18 degrees 50 min.), in the Western Cape Province
and the Grootfontein Agriculture College in Middelburg (Lat. 31 degrees 29 min., Long. 25
degrees 02 min.) in the Eastern Cape Province.
2.1.1 RELIEF FEATURES
The surface area of South Africa falls into two major physiographic provinces: the interior
plateau, comprising extensive level surfaces with a mean altitude of 1200 m (Middelburg) and
the marginal lands (Stellenbosch) between the plateau and the coast. Forming the boundary
between these two areas is the Great Escarpment. lts height above sea level varies from 1500 m
in the Namaqualand to a height of 3482 m in the Kwazulu Natal Drakensberg. Inland from the
escarpment lies the interior plateau, which is the southern continuation of the great Africa
plateau stretching north to the Sahara (SA Yearbook, 1998). The altitude of the locations of the
study is 85 m for Stellenbosch and 1270 m for Middelburg.
2.1.2 CLIMATIC FEATURES
The climate at any place on earth is mainly controlled by latitude, position relative to
distribution of land and sea, height above sea level, general circulation of the atmosphere and its
local effects, influence of ocean currents, and position relative to hills and mountains (Anderson,
1969). The subtropical location, south of 30 degrees south, accounts for the warm temperature
conditions so typical of South Africa. The country also falls squarely within the subtropical belt
of high pressures, making it dry, and with an abundance of sunshine. The wide expanses of
ocean on three sides of South Africa have a certain moderating influence on its climate. More
apparent, however, are the effects of the warm Agulhas current (south-flowing stream skirting
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the east and south coast as far as Cape Point) and the cold Benguela current (flowing north along
the west coast as far as southern Angola). While Durban (east coast) and Port Nolloth (west
coast) lie more or less in the same latitude, there is a difference of no less than 6°C in their mean
annual temperatures. Even more significant is the effect on rainfall. Because east coast air
masses are warmer, they tend to be less stable and more likely to cause abundant rain. Indeed
moist, warm air masses from the Indian Ocean are in fact the chief source of rainfall for most of
the country. The cold water of the Benguela current, by contrast, chills from beneath west coast
air masses. Coupled with others conditions, rain-forming processes are therefore severely
discouraged, hence Port Nolloth's meager annual total rainfall of only 63 mm. Durban (east
coast), on the other hand, records 1018 mm of rain annually (SA Yearbook, 1998.)
South Africa has an average annual rainfall of only 464 mm, against a world mean of 857 mm.
Sixty- five percent of the country has less than 500 mm annually, usually regarded as the
absolute minimum for successful dryland farming. The distribution of annual precipitation has
two main features. Firstly, there is a fairly regular decrease over the plateau from east to west.
The moist Indian Ocean air masses gradually lose their moisture as they move towards the
western interior. The very lowest rainfall - less than 50 mm in places - occurs on the west coast
in Namaqualand (Northern Cape). The second main feature of the rainfall distribution pattern is
the strong orographic influence. In the Wemmershoek and Jonkershoek mountains (near the
Stellenbosch embryo station) of the south-western Cape, an annual rainfall figure as high as
3200 mm have been recorded. Using periods of maximum rainfall as a measure, three
precipitation sub-regions can be distinguished. The winter rainfall region is a comparatively
small area along the Cape west and southwest coasts and has a Mediterranean rainfall pattern,
with a prominent winter maximum. In this study, Stellenbosch annual rainfall of 633 mm
belongs to the winter rainfall region. The summer rainfall region covers most of the rest of the
country. Middelberg (Grootfontein) with an annual rainfall of 360 mm is located in this region.
Between the winter and the summer rainfall regions lies a transitional area where rain falls in all
seasons (SA Yearbook, 1998).
South Africa's rainfall is unreliable and unpredictable. Large fluctuations in the average annual
figure are the rule rather than the exception in most areas of the country. Years with a
below-average figure are more common than years with an above-average total. As is the case
of other countries in similar latitudes, South Africa is periodically afflicted by severe and
prolonged droughts, which often end in severe floods (SA Yearbook, 1998).
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Three main features characterize temperature conditions. Firstly, the temperature tends to be
lower than in other countries in a similar latitude, for example North Africa and Australia. This
is primarily due to the greater elevation above sea level of the subcontinent. Secondly, despite a
latitudinal span of 13 degrees, average annual temperatures are remarkably uniform throughout
the country. The third feature is the striking contrast between temperatures on the east and west
coasts. Mean annual temperature figures, however, conceal almost as much as they reveal. This
is shown by an examination of extreme temperatures, and seasonal and daily ranges. The mean
annual temperature recorded in Stellenbosch (1994) was 18°C, and in Middelburg (1920-1962)
was 14.5°C, (SA Yearbook, 1994).
2.2 ANIMAL MANAGEMENT
Experiments were conducted on two farms where goats were kept in intensive management
systems. Each of these farms housed an embryo-collection unit, the African Embryos and
Semen (AES) Station in Stellenbosch and the Grootfontein Agricultural College Embryo Station
(GACES) in Middelburg.
2.2.1 AES STELLENBOSCH
The animals were all housed in well sheltered and ventilated woody (females) and brick worked
(males) barns under roof by night with a provision of pellets and lucem ad libitum. During the
day the animals were permitted to browse on Kikuyu grass (Penicetum clandestinum ) while
pellets was given ad libitum as well. The approximate daily quantity of pellets taken per animal
was 0.5 kg. The commercial pellet given was Budget Pride 12 (Table 2-1). The bucks were
sheltered in a separated bam from the does during the night, and kept in open-air camp next to
that of the does during the day. Water was always freely available. Four weeks prior to the
starting of the experiments, all animals were given Zn, Mn, Se and vitamin A injections,
vaccinated against Pasteurella and pulpy kidney disease, and treated against worms with
Avermectin (Ivomec, Logos Agvet). Oxytetracycline was injected in those animals showing
disease symptoms of coughing.
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Table 2-1 Composition of the AES pellets ration (Budget Pride 12)
Ingredient Quantity Unit Maximin
Protein 120 g/kg Min
Fat 25 g/kg Min
Fibre 90 g/kg Max
Moisture 120 g/kg Max
Calcium 15 g/kg Max
Phosphorus 6 g/kg Min
Urea 10 g/kg Max
Body conditions of animals were assessed and dentition used to estimate the ages. Average
body condition of the herd was about three in a scale ranging from one for poor to five for
excellent condition. The experimental animals were randomly chosen upon the base of body
condition.
2.2.2 GACES MIDDELBURG
The animals were kept in well-ventilated pens under roofby night and in a well-fenced open-air
camp during the day. Pellets (Table 2-2) and lucerne hay were given ad libitum. The
approximate daily ration per animal was 1.75 kg of pellets, and 750 g of lucerne hay. Males
were separated from females and water was freely available to both sexes.
Table 2-2 Composition of the GACES pellets ration
Ingredients Percentages
Crude protein 12.9%
T.D.N. 68.3%
Crude fiber 11.3%
Metabolizable energy 10.3 Mj /kg
Calcium 1.18%
Phosphorus 0.29%
By the time of the arrival of the goats at the embryo station farm, one month before the
beginning of the experiment, the general condition of the animals was very bad, especially
because of their previous poor nutritional status consisting of an unimproved pasture diet
without any supplementation. The average weight of the donors then was about 42 kg. Three
months later, the average weight of donor animals was 47 kg and 52 kg six months later.
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Fig. 2-1 Location of the study in South Africa
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CHAPTER3
SUPEROVULATION, SYNCHRONIZATION AND
FERTILIZATION
3.1 SUPEROVULATION
Superovulation is defined as the treatment of a female with hormones to allow more ova to be
ovulated than the usual (one or two). In this process, ovaries are stimulated to produce more
than the normal number of ovulatory follicles and thus release more ova. In order to exploit the
superior genetic potential of an outstanding female to the full, using embryo transfer, it is
obviously essential to obtain as many eggs as possible from that female (Peters & Ball, 1987).
With current procedures, superovulation increases the yield of normal embryos about fivefold in
the cow, goat, sheep, and rabbit (Hafez, 1993).
In cattle, superovulation typically results in the ovulation of about 10 ova, six of which are
recovered as normal embryos (Seidel & Elsden, 1989.) In goats and sheep about 10 to 12
normal embryos should be recovered (Table 3-1). In all species, there are tremendous individual
variations in response and wide ranges in superovulatory response and embryo yield have been
revealed in several reviews of commercial embryo transfer. The variability in response to
current superovulatory regimes is one of the problems limiting the success of multiple ovulation
and embryo transfer (MOET) programs (Wallace, 1992; Mapletoft & Bo, 1994). Therefore,
much research effort has been directed toward improving superovulation regimes. This
variability in ovarian response has been related to differences in superovulatory treatments such
as gonadotropin preparation, the batch of gonadotropin, the duration of treatment, the timing of
treatment with respect to the estrous cycle, the total dose of gonadotropin, the use of additional
hormones in the superstimulatory scheme and other additional factors.
To date, the gonadotropin preparations most frequently used include pregnant mare serum
gonadotropin (PMSG), porcine follicle stimulating hormone (FSH-p), horse anterior pituitary
extracts (HAP) and human menopausal gonadotropin (hMG) (Wallace, 1992). Discovered in
1930 by proff. Cole and Hart at the university of California at Davis, according to Peters & Ball
(1987), in the serum of pregnant mares, PMSG has been found to have both FSH-like and
LH-like proprieties. It differs from the endogenous pituitary gonadotropin in cattle (LH and
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FSH) in that it has a much longer half-life in the body (in excess of 50 h) as compared with
approximately 0.5 - 1 h for LH and FSH (Peters & Ball, 1987).
Traditionally, a single injection of 1500 to 3000 ru of PMSG has been used to superovulate
cows. However, more ovulations, embryos recovered and pregnancies have been reported after
a superovulatory regimen with FSH and LH in as: 1 ratio, administered twice a day in
decreasing doses for 5 days (Mapletoft, 1986). Another treatment commonly used, especially
because of its simplicity in on-farm work, is 5 mg FSH daily for 5 days (Mapletoft, 1986). It has
been demonstrated that an improved response could be obtained when LH was not added in
decreasing doses for 5 days. FSH and PMSG may be given either subcutaneously or
intramuscularly (Mapletoft, 1986). The majority of donor cows will respond most predictably
and optimally if superovulation treatments are instituted between days 8 and 14 of the cycle
(Mapletoft, 1986).
Table 3-1 Distribution of ovulation rate following various superovulatory hormone regimes
(Wallace, 1992)
Superovulation No of ewes No of ewes with
Program treated ovulation rates
#4 35
hMG2 23 3 20
HMG 10 5 5
PMSG 3 + GnRH 4 73 24 49
PMSG+GnRH 48 26 22
PMSG+GnRH 38 11 27
porcine FSH 5 43 4 39
porcine FSH 46 17 29
Mean ovulation rate
±Sem 1
All ewes Ewes with
CL35
11.6± 1.31 13.1 ±1.21
7.7± 2.30 13.2 ± 2.94
8.4 ± 0.75 11.0 ± 0.90
5.2 ± 0.64 7.8±1.17
8.9 ± 1.11 11.5 ± 1.27
14.2 ± 1.24 15.3 ± 1.24
7.6 ±0.82 10.5 ± 0.95
1 Sem: Standard error of mean
2 hMG: Human Menopausal Gonadotropin
3 PMSG: Pregnant Mare Serum Gonadotropin
4 GnRH: Gonadotropin Releasing Hormone
5 FSH: Follicle Stimulating Hormone
Boer goats can be superovulated during the breeding and anestrous seasons. Some reports
suggest a slightly lower response during the anestrous period, particularly for those breeds with
strict seasonal limitations on cyclic behavior. The use of PMSG and FSH both have now been
used successfully for over a decade to superovulate donor does. Over the years, however, FSH
stimulation has been reported to produce more normal corpora lutea and better quality embryos
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for transfer in both breeding season and non breeding season does than PMSG (Armstrong et ai,
1982 a, 1982 b), (Pendleton et al., 1992). Table 3-2 lists the timing and the doses for PMSG
and FSH in goats. In the cyclic donor, gonadotropins are administered near the end of the luteal
phase of the cycle (days 17 to 18) so that follicles are recruited before lysis of the existing CL
(Bondurant, 1986).
Table 3-2 Superovulation in goats (Bondurant, 1986)
Drug Total dose/route Day of estrous cycle Comments
PMSG 1000 to 2000 ru IM 14 to 18 Single injection
FSH 18 to 24 mg IM or SC.
(begin at 5 mg)
Begin days 13 to 16 Twice daily decreasing
dose for 3 to 4 days
Because effective functional estrous detection requires much time, labor, skill and expense, it
has been cited as a major factor limiting the widespread use of artificial insemination in cattle
(and goats). Therefore, the elimination of estrous detection from artificial breeding programs
was the principal stimulus that led to research in the development of prostaglandin and
progestational compounds that have the ability to control estrus without affecting fertility
(Wenkoff, 1986). Estrous control offers several applications in addition to synchronized
breeding programs in farm animals. Estrous synchronization in embryo transfer programs is one
thereof.
3.2 ESTROUS SYNCHRONIZATION
The control of the estrous cycle is dependent on manipulation of the hormonal events occurring
during the normal ovarian/estrous cycle. The overriding event controlling the development of an
ovarian follicle to the point of ovulation in the cyclic cow (or doe) is believed to be the process
of luteolysis or decrease in progesterone secretion occurring at the end of the luteal phase of the
cycle (Peters & Ball, 1987). The fall in peripheral progesterone concentrations may be
manipulated artificially in two ways, by: 1) Artificial induction of premature luteolysis using
luteolytic agents, for example, prostaglandin F2u; 2) Simulation of CL function by
administration of progesterone (or one of its synthetic derivatives) for a number of days,
followed by abrupt withdrawal (Peters & Ball, 1987).
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3.2.1 INDUCTION OF LUTEOLYSIS
The single greatest advance in superovulation methodology in the last decade has been the use of
prostaglandin F2a or PGF2a analogues, such as cloprostenol, because superovulatory treatment
can be initiated anytime between day 6 of the estrous cycle and natural CL regression. The
optimal time for treatment however is between days 8 and 12 of the cycle in cattle (Betteridge,
1977), because the luteolytic rate is low in young corpora lutea (days 5 to 6) and does not
approach 90% until the CL is over 7 to 9 days old (Wenkoff, 1986). Injection of exogenous
PGF2a or one of its analogues during the mid-luteal phase of the cycle, results in a premature
luteolysis and consequential fall in peripheral progesterone concentrations. This is followed by
a rise in secretion of gonadotropins and estradio-Db culminating in the pre-ovulatory (LH and
FSH) surges and eventual ovulation (Peters & Ball, 1987).
Normally, a luteolytic dose of prostaglandin F2a is administered 48 to 72 hours after initiation of
superovulatory treatment. Estrus is expected to occur around 48 hours after the administration
of PGF2a. Cows that are late coming into heat by one or more days usually yield poor results.
Occasionally, estrus will occur 12 to 24 hours early. These cows usually have a good
superovulatory response with good embryo quality. Once heat is expressed, treatments cease
and inseminations (or natural service) begin. If ovulation problems are suspected in a given
donor cow (based on previous experience), 2500 ru of hCG or 200 ug of GnRH may be
administered at the onset of heat. Donor cows can be superovulated every 50 to 60 days rather
indefinitely. However, it is often useful to allow a donor cow to have a calf to rejuvenate the
system and to milk some fat off her back (Mapletoft, 1986). Prostaglandins have been used to
control the estrous cycle in several different ways. One possible method, the so-called "two plus
two" or "double-injection" technique, was designed to synchronize groups of animals cycling at
random without prior knowledge of their precise ovarian status. All cattle are injected on day 0
of treatment and the injection repeated 10 days later. AI is then carried out usually three and
four days after the second PGF2a injection (Peters & Ball, 1987).
Prostaglandin F2amanipulates the reproductive events of goats very effectively. PGF2a has been
used successfully in dairy goats for the induction of estrous and synchronization of estrus among
others applications (Ott, 1986). During the breeding season, synchronization may be achieved
by inducing resorption of the CL with PGF2a and, therefore, shortening the cycle. Prostaglandin
F2a injection has been shown to be effective on any doe that is between days 4 to 17 of the
estrous cycle. Does which are on day 18 or later will soon come into estrus anyway. PGF2a will
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not cause does on days 1,2, or 3 to come into estrus early (Ott, 1986). Does in this category are
unresponsive to PGF2a receptors for the simple reason that the corpus lutea present have very
few PGF 2a receptors at that stage. However, seven days later, these does will now be between
days 8 and 10, in mid-luteal phase, and therefore responsive to prostaglandin. Successful
induction of estrus with PGF2a in goats treated as early as day 4 of the estrous cycle indicates
that PGF2a is luteolytic at an earlier stage of the estrous cycle in goats than sheep or cattle
(Bretzlaff et al, 1983). In sheep, prostaglandin will not induce luteolysis prior to days 4 to 5 of
the cycle.
It is often necessary to control the time of estrus and ovulation in donors so that gonadotropin
treatment can be administered properly timed to the recruitment of follicles and subsequent
estrus. When information is available about the stage of the donor's estrous cycle, a single
injection of PGF2a given two days after initiation of gonadotropin treatment (middle to late
cycle) will induce estrus in one to four days. In goats for which no such information is
available, two injections ofPGF2a may be given 10 to 12 days apart. Gonadotropin treatment is
begun 2 days before the second injection of PGF2a (Bondurant, 1986). Prostaglandins are not
effective when administered to anestrous does outside the breeding season, because the ovary
can only respond to prostaglandin ifthere is a functional corpus luteum. Therefore, does with no
ovarian activity during the anestrous period, will not respond to prostaglandine F2a
3.2.2 USE OF PROGESTAGENS
The second method of controlling the cycle is to simulate the function of the CL by the
administration of progesterone or one of its derivatives. In this method, gonadotropin release,
and hence follicular maturation, is suppressed until progesterone withdrawal.
If a group of cows is treated with progesterone and the progesterone is then withdrawn from all
cows simultaneously, this will theoretically synchronize ovulation in the group. In order to
synchronize a group of randomly cycling cows effectively, it is necessary to treat them with
progesterone for a period equivalent to the length of the natural luteal phase i.e. at least 16 days.
This is due to the fact that exogenous progesterone has little or no effect on the life span of the
natural CL and therefore in some cases the natural CL might outlive a short-term progesterone
treatment, resulting in a failure of synchrony. However, it has been shown that long-term
progesterone treatments (18-21 days) result in poor pregnancy rates. Shorter-term progesterone
treatments generally result in a more acceptable pregnancy rate. Unfortunately short-term
progesterone treatment does not control the cycle adequately. If treatment is started early in the
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cycle, the natural CL may outlast the progesterone treatment. Therefore, it is necessary to
incorporate a luteolytic agent with short-term progesterone treatments in order to eliminate any
natural corpus luteum (Table 3-3). Prostaglandin is usually injected on the day before
progestagen withdrawal (Peters & Ball, 1987).
Table 3-3. The effect of a nine-day progestagen treatment without a luteolytic agent on the
estrous cycle in cow (Peters & Ball, 1987)
Stage of cycle at
implant
Will the cows
synchronize?
Mechanism
Days 9-17 Yes Treatment coincides with or outlasts
corpus luteum.
Days 18-1 Yes Progesterone blocks ovulation.
Days 2-8 No Corpus luteum outlasts progesterone
treatment.
Progestagens (progesterone-like compounds) can be administered in the feed, by injection or by
implant. Treatment by food requires that the compound is "orally active," i.e. that it is absorbed
into the systemic circulation unchanged. However, this route of administration presents
problems of controlled dosing. Progestagens can be given by injection, but repeated treatments
may be necessary and the rate of absorption may be too imprecise to allow synchronized
withdrawal of the compound. Implants are the most suitable method of administration of
progestagens since withdrawal can then be precisely controlled by implant removal (Peters &
Ball, 1987).
Because progesterone itself is relatively inactive orally, some synthetic analogues such as
medroxyprogesterone acetate (MPA) and melengestrol acetate (MGA) were developed in the
mid 60's as possible synchronization compounds. The level of synchrony was adequate, but
conception rates were low because of delayed embryo cleavage. The recently developed
synthetic progesterone, norgestomet, on the other hand, can be used to synchronize estrus
without lowering fertility. Norgestomet (also called Crestar in RSA or Synchro-Mate B in the
USA) consists of an impregnated silastic subcutaneous implant (Wenkoff, 1986; Peters & Ball
1987).
Used in the cow, Synchro-Mate B (SMB)/Crestar treatment consists of an ear implant that
contains 3 mg of norgestomet and an intramuscular injeetion of 5 mg estradiol valerate and 3 mg
norgestornet mixed together in a single 2 mL dose (Fig. 3-2). The norgestomet acts as "artificial
CL" and therefore prevents the LH surge and ovulation, CL formation, and CL maintenance.
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When the implant is removed 9 days later, the pituitary gland is released from the inhibitory
effects of norgestomet, and the animal returns to estrus 24 to 36 hours later (Wenkoff, 1986),
(Miksch et al, 1987). In either cyclic or anestrous donors does, estrus and ovulation may be
controlled with progesterone or synthetic progestagins (Table 3-4).
Table 3-4 Estrous control in goats (Bondurant, 1986)
Drug Dose Route Duration of Comment
treatment (da~s)
Progesterone 10 to 12 mg IM 14-18 In oil
Fluorogestone acetate 30 to 45 mg Vaginal 14-18 Immature animals
(FGA) = Cronolone pessanes may require higher
dose
Methyl- 60mg Vaginal 14-18
acetoxypro gesterone pessanes
(MAP)*
PGF2a 4 to 10 mg IM 1 At mid-cycle
Cloprostenol 100 to 250 IM 1 At mid-cycle
mg
*MAP: also referred to as Medroxyacetate progesterone (Hafez, 1993) or Medroxyprogesterone acetate (Peters &
Ball, 1987).
During the breeding season, synchronization may be achieved by overriding the goat's system
with exogenous progesterone to prolong a cycle. Progesterone used to prolong the estrous cycle
can be supplied in several forms. When fluorogestone acetate (FGA, 45 mg) impregnated
vaginal pessaries are implanted for 16 to 21 days (preferably with administration of 400 to 500
ru of PMSG at the time of removal), ovulation has been successfully induced with 55 to 90 per
cent fertility. Estrus occurs 20 to 40 hours after sponge removal. To avoid the difficulties
sometimes associated with pessaries (the evident mucopurulent vaginal discharge at the sponge
removal, possible extraction of sponges by others goats in the pen), removable subcutaneous
implants of 375 mg progesterone or 60 to 70 mg MAP in silastic tubing have been used instead
(Smith, 1986).
An intra-vaginal device consisting of 9% (w/v 0.38 g) progesterone (Fig. 3-1), moulded over a
nylon core called Controlled Internal Drug Release dispensers (CIDRs) have been claimed to
have a much less foul-smelling discharge (mucus) on removal. CIDRs also has a lower rate of
loss during treatment and a quicker reaction time, i.e. earlier and more compact synchronization,
when compared to the intra-vaginal progestagen sponge in sheep (Harvey et al., 1984; Welch et
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al., 1984). A portion of a bovine norgestomet implants (3 mg/goat) described above is another
alternative.
Outside the breeding season, progestagen vaginal pessaries have been used with variable results.
FGA sponge implanted for 16 to 21 days can be used successfully (40 per cent conception with
AI) and administration of 400 to 600 ID of PMSG 48 hours before sponge removal improves
fertility up to 65 per cent conception rate (Smith, 1986).
3.3 FERTILIZATION
3.3.1 NATURAL BREEDING
In wild animals, there is a well-defined breeding season when both sexes show sexual activity.
Many wild species of bovidae are seasonal breeders. The change in the daily photoperiod is the
cue for the onset or termination of ovarian activity. Spring and summer in these species are the
most suitable times of the year for calving. During the course of domestication, both dairy and
beef cattle were selected against seasonality, facilitating them to ovulate and conceive
throughout the year. However, beef cows might remain sensitive to photoperiodicity. A
seasonal variation of fertility in temperate climates only becomes evident after studying a large
number of herds over a period of several years (Hafez, 1993).
Some goat breeds are seasonally polyestrous so that the young are born during the most
favorable time of the year, namely the spring. The length of the sexual season varies with day
length, breed and nutrition. This seasonality is governed by photoperiodicity with estrous
activity commencing during a period of decreasing day length. In temperate zone latitudes, most
breeds of goats are anovulatory and in anoestrus during spring and summer, but start cycling as
the length of daylight decreases during fall. In the tropical zones, where there is less variation in
day length, indigenous goats tend to breed throughout the year. High environmental
temperatures and lack of feed may restrict sexual activity during some months of the year in the
tropics. In sheep and goats there are important breed differences in the duration of the sexual
season (Hafez, 1993).
Although periods of complete anestrus were never observed within the Boer goat herd, it would
appear that the Boer goat doe is seasonally polyestrous, with an extended breeding season. In
the southern hemisphere, the seasonal pattern displays the peak of sexual activity during April
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and May (autumn) and the period of lowest sexual activity from October through January (late
spring to mid-summer), (Hofmeyr et al, 1966; Greyling, 1988).
In farm animals (cows, goats), mating is limited during estrus, coinciding with the time of
ovulation. The duration of estrus is species-dependent (32 to 40 hours in goats and 18 to 19
hours in cows) and varies slightly from one female to another within the same species (Table 3-
5). This is also true in respect to the time of ovulation, which occurs 32 to 36 hours from the
beginning of estrus in the goat, 10-11 hours after the end of estrus in the cow. The length of
estrus and time of ovulation also vary in relation to internal and external factors. In ewes the
interval between the onset of estrus and LH ovulatory surge (and therefore the interval between
estrus and ovulation) lengthens as the number of ovulation increases (Hafez, 1993).
In the mature Boer goat, the mean duration of a natural estrous period was recorded as 37.4
hours, with a variation from 24 to 56 hours between animals. The mean time of ovulation in
Boer goats (from the onset of the estrous period) is 36.8 hours (86.7% of does ovulating 38
hours after the onset of estrus). The mean time interval between the onset of estrus to the LH
peak is 11.6 hours (Greyling, 1988).
Goats have fairly high fertilization rates after superovulation. The general rate of ovum
fertilization for goats tends to be higher than for sheep, and natural mating of superovulated does
is generally successful. Fertilization rates after artificial insemination of superovulated does
have not been as high (Bondurant, 1986).
Table 3-5 Estrous cycle, estrus, and ovulation in farm animals (Hafez, 1993)
Length of estrus cycle Duration of estrus Time of ovulation
(days) (hours)
Sheep 16-17 24-36 30-36 hours from beginning of estrus
Goat 21 (Also short cycle) 32-40
Cow 21-22 18-19 10-11 hours after end of estrus
3.3.2 ARTIFICIAL INSEMINATION
Artificial insemination (AI) is the most important single technique devised for the genetic
improvement of animals. This is possible because a few highly selected males produce enough
spermatozoa to inseminate thousands of females per year, whereas only relatively few progeny
per selected female can be produced per year even by embryo transfer. AI has many advantages
to offer the dairy farmer but the problem of estrus detection limits its value in beef herds (Peters
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& Ball, 1987). Major advantages of AI as opposed to natural service include genetic
improvement, venereal disease control, cost effectiveness, and safety through elimination of
dangerous males on the farm, and in cows, flexibility (Peters & Ball, 1987). In spite of these
advantages, AI is used in probably only 5 per cent of beef cows in the UK and in the USA,
whereas most dairy herds use an AI service. Most of the world's population of sheep and goats
is managed under free ranging conditions where natural mating is widely practised. Unlike with
cattle, AI of sheep and goats has been generally limited, owing to the high cost ot labor,
difficulty of accurately identifying superior sires, and low conception rates, especially with
frozen semen (Hafez, 1993).
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CHAPTER4
EMBRYO RECOVERY AND EVALUATION
4.1 EMBRYO RECOVERY
Embryos can be collected from the oviducts or uteri after the slaughter of the animal or the
excision of the reproductive tract, or they can be removed either surgically or non-surgically
from the intact animal (Hafez, 1993). Prior to 1976, most bovine embryos were collected via
mid-line laparotomy or, less commonly, via a flank incision. In that year, several groups
published efficacious methods for non-surgical (transcervical) recovery of embryos, and the
industry changed to these procedures rather abruptly (Betteridge, 1977). Ova representing 40 to
80% of the corpora lutea can usually be recovered from superovulated, intact animals. However,
recovery rates are slightly higher from excised tracts (Hafez, 1993). For many applications, non-
surgical techniques for the collection of ova are desirable, because all surgical techniques may
lead to the formation of adhesions to the reproductive organs. There is also less risk to the life
and the health of the donor with the non-surgical methods (Hafez, 1993).
In goats and sheep, the majority of embryo recoveries in multiple ovulation and embryo transfer
schemes are carried out via mid-ventral laparotomy under general anaesthesia. The limitations
of current superovulation treatments require that females on genetic improvement programs be
flushed repeatedly. The formation of adhesions following surgical embryo recoveries severely
limits the number of times an animal can be flushed, and often compromises its ability to breed
naturally. It was for this reason that non-surgicallaparoscopic procedures to repeatedly recover
embryos were developed at the Rowett Research Institute (McKelvey et al., 1986).
4.2 EVALUATION OF EMBRYOS
4.2.1 EMBRYOLOGICAL TERMINOLOGY
The terminology of embryo transfer can be confusing, even to the scientists. One of the reasons
for confusion is that different terms are used in different countries. Following are some terms
used commonly in the field of embryo transfer as explained by G E & S M Seidel and R P
Elsdein in their books Embryo Transfer in Diary Cattle (1989) and Training Manual for Embryo
Transfer in Cattle (1991).
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In mammals, the female gamete ovulated is called an egg or ovum (Latin word for egg); the
correct technical term for the newly female gamete is an oocyte. Upon fertilization, the oocyte
matured into ovum becomes a one-cell embryo, sometimes referred to as a zygote. The embryo
then divides into two cells, four-cells, eight-cells. At the 16-cells stage, the embryo becomes a
morula (Latin for mulberry). When a cavity (blastocoele) forms betwe-en the cells of the
embryo, it is termed a blastocyst. To add further confusion, all of these stages are frequently
called eggs or ova. During the morula stage, cells of embryos change from spherical to
polygonal in shape. This phenomenon is termed compaction (compacted morula). Frequently,
compacted morulae are termed tight morulae. Compacted morulae are smaller than pre-
compacted embryos. Compaction is an excellent sign that the embryo is developing normally;
lack of compaction by the sixth day after estrus in cattle and goats indicates retarded
development. As a morula develops into a blastocyst, it forms a cavity (the blastocoele) by
expending energy to pump fluid between the cells. Thus blastocyst formation also is indicative
of continued normal embryonic development. Conversely, lack of blastocoele formation by
seven days after estrus in cattle and goats signifies retarded development.
The zona pellucida is a gelatin-like capsule that surrounds the oocyte and early embryo. It has
receptors for sperm that are inactivated after fertilization; it keeps the cells of the pre-
compaction embryo together, and protects these young cells from the immune system and from
pathogens. If the zona pellucida is removed from pre-compaction embryos, the cells come apart
upon embryo transfer and then degenerate. When the bovine blastocoele becomes very large,
the embryo expands (normally 8 to 9 days after estrus), which thins the zona pellucida. This is
the expanded blastocyst stage. After one to one days more, the expansion is so great that the
embryo hatches out of the zona pellucida, perhaps aided by enzymes. A hatched blastocyst
become ellipsoid in shape 11-13 days after estrus and then elongates markedly by 14-16 days
post-estrous.
4.2.2 EVALUATION
One problem is terminology for evaluation of ova recovered from donors. They can be
classified based on appearance as unfertilized or fertilized, and as ranging in quality from
degenerated or very poor to excellent. The exact terminology varies considerably among
technicians who evaluate embryos. Frequently embryos are classified on a scale of one to three,
one to four or one to five, but for some systems one is best and for other systems one is worst.
In the end, however ova always are placed into two groups, those not worth transferring and
those worth transferring; the later are said to be "transferable" (Seidel & Elsden, 1989).
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Morphological microscopic appraisal is the most practical criterion for evaluating embryos. The
microscopic inspection of ova and embryos at 70X magnification permits classification of
uncleared, degenerated, delayed, or regular embryos (Baril et al., 1989). In summary, they are
considered normal if blastomeres are uniform in size and spaced regularly within the zona
pellucida. Quality is assessed by the stage of development, integrity of the zona pellucida,
nature of the shell surrounding the embryo, color and texture of the cytoplasm of the embryo.
There are three elements to successful evaluation of embryos: training, experience, and proper
equipment. Training includes learning the correct morphology of embryos at different times
post-estrous (Table 4-1). One must also learn how to manipulate and examine embryos.
Experience is gained by examining many embryos at different stages of development. Ideally
hundreds of embryos should be studied under the guidance of someone experienced in this area.
Photographs, drawings or slide of different kinds of embryos are useful. However, they can only
substitute partially for real embryos. As for the equipment, with a good stereomicroscope at
X30 to X40 magnification or less, an experienced technician can evaluate more than ninety
percent of embryos accurately. However, a small percentage of embryos require a compound
microscope (at least a XI0 objective with X8 to X20 eyepieces) for accurate evaluation. For
learning purposes, a compound microscope is especially useful.
It is important to be able to recognize the various stages of development and to compare these
with the developmental stage that the embryo should be at, based on the occurrence of heat
(Table 4-1).
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Table 4-1 Stages of embryonic development at various times afterestrus
Stage of embryonic development Days after ovulation, by species
Cow Goat
1 Cell 0-1 0-1
2 Cell 0-2 0-1
4 Cell 1-2 1-2
8 Cell 2-4 2-3
Early morula (EM) 3-5 2-4
Compacted morula (CM) 4-6 4-5
Early blastocyst (EB) 6-7 5-6
Blastocyst (B) 6-8 6-7
Expanded blastocyst (EB) 7-9 7-8
Hatching blastocyst (HB) 8-10 7-9
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CHAPTER 5
MATERIAL AND METHODS
5.1 ESTROUS SYNCHRONIZATION
5.1.1 SYNCHRONIZATION PRODUCTS
Synchronization was performed by the administration of progestagen alone or in combination
with estradiol depending on the superovulation program used. Four products were used:
Synchro-Mate-B (SMB)/Crestar and Controlled Internal Drug Release (CIDR), as progestagen
implants; Estradiol Cypionate (ECP) and Estrumate (Cloprostenol), a prostaglandin analogue,
were given as luteolytic agents.
Synchro-Mate-B (SMB)/Crestar (Intervet SA. 86/2 86/1) consists of a subcutaneous ear
implant impregnated with 3-mg norgestornet, inserted by means of a special syringe on day 0
(Fig. 5-1). In this study, a subcutaneous ear implant containing 3 mg (SMB xl) or 6 mg (SMB
x 2) of norgestornet, depending on the superovulation program used, was inserted for 13 to 17
days. This norgestomet treatment was in combination with either ECP on day one or no ECP
administration. The principle of the insertion and the removal of the implant of the goat are
similar to that shown in cows (Fig. 5-1). The Crestar implant was removed on day 13 by making
a small scalpel incision in the skin of the ear at the implant entry point, and pulling the implant
out of there by means of haemostat forceps. In some cases the spot of the needle entrance at the
time of implant was slightly swollen and infected, easing the pulling out of the implant removal
without the need of any incision. To avoid such infection, the spot of implant behind the ear was
carefully disinfected with 70% alcohol prior to the implant.
Controlled Internal Drug Releases (CIDR) (EAZI-breed CIDR G, Solvay A.H) device consists
of a silicone rubber elastomer moulded over a nylon spine, containing 0.33 grams of natural
progesterone. The device was administered intravaginally using the specifically designed
applicator. Placed in the applicator rod hole through its tip, the wings of the device folded
inward and were held in the folded position by the applicator. Squeezing of the plunger handle
expelled the device in the anterior part of the vagina. When in place, the nylon string attached to
the device protruded from the vulva. Between each insertion the applicator was plunged in an
antiseptic solution Rocal II (quantenary ammonium compound, QAC), and then rinsed in clean
water to prevent any vaginal infection spreading from one animal to the next one. The applicator
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was coated with lubricant when needed (e.g. for a doe with a restricted vaginal opening) to ease
the applicator penetration. The removal at the end of the required time, according to the
program used, was achieved by gently but firmly pulling on the nylon string of the device.
CIDR G was used in a single dose (CIDR xl) or in a double (CIDR x 2), either in combination
with estradiol at the device insertion or not.
Estrumate (Cloprostenol, Hoechst Ag-Vet) is a synthetic prostaglandin F2a which is a potent
luteolytic agent consisting of 250 ug per mL of the solution. In this study 0.5 mL of Estrumate
(125 ug) was administered intramuscularly 12 hours before progestagen implant (SMB or
CIDR) withdrawal.
Estradiol Cypionate (ECP, Upjohn) consists of 2 mg per mL of estradiol cypionate. In this
study 0.25 mL (0.5 mg) was administered intramuscularly on day one and used for two reasons:
1) to destroy the CL within its first 4 days of life (during metestrus stage); 2) to stop follicular
wave development to allow the stimulation of a new wave of follicular development before the
dominant follicle has been identified that will suppress the development of inferior follicles.
5.1.2 SYNCHRONIZATION TREATMENTS
Goats (n=367) were assigned to different synchronization treatments using 2 different products
5MB (Crestar) and CIDR as shown in the table below.
Table 5-1 Summary of different synchronization (Synchro) treatments used during the
experiment
Synchro Synchro Dosage & Other treatment Symbol Number of
groups drug administration used goats
1 5MB 3 mg norgestomet No farther treatment 5MBx 1 123
inserted from 13 to 17
days.
2 5MB 3 mg norgestomet One more implant of3- 5MBx2 32
inserted for 10 days. mg norgestomet inserted
from day 10 to17.
3 CIDR 0.33 g of natural No farther treatment CIDR xl 187
progesterone inserted
from 13 to 17 days.
4 CIDR 0.33 g of natural One more implant of CIDRx2 25
progesterone inserted 0.33 g of natural
for 9 days. progesterone inserted
from day 9 to 17.
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Estradiol Cypionate treatments were given to ECP group 1 goats (n=112) while ECP
group 2 goats (n=255) did not get ECP treatments as shown in the table below.
Table 5-2. Summary on the use of Estradiol cypionate treatments during the
experiment
ECP use groups Dosage & administration Symbol
used
Number
of goats
Estradiol
Cypionate (ECP)
was used
0.5 mg ofECP injected intra-
muscularly on day one after implant
insertion
ECP used 112
2 Estradiol
Cypionate (ECP)
was not used
NoECP 255
!~_PLA~~! iNSERTION
UPPER EAR MARGIN
SKIN VERY TIGHTLY
ADHERENT TO CARTILAGE
AND VASCULAR
LOWER EAR MARGIN
CR£STAR ® eerrenses.
Implan! containing
3mg norqestomet,
Injection containing
3mg norgestomei
and 5mg oestradiol valerate.
For use only in bee! animals
and maiden dairy heilers.
Not to be adrninistered to
animals producing mAk lOf
human consumption.
Legal category:PDM
IMPLANT REMOVAL
Fig. 5-1 Crestar implantation and removal technique
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5.2 SUPEROVULATION
5.2.1 SUPEROVULATION PRODUCTS
Two ovine FSH preparations, Embryo-S (E-S) and Ovagen (Dv) were used. These products
were either used alone or combined with PMSG, depending on the superovulation program used.
Pregnant Mare Serum Gonadotropin (PMSG) (Fostim, Upjohn) was administered
intramuscularly as a single dose of 300 ru, 48 to 72 hours prior to the implant removal.
Supplied as a white-dried crystalline powder of serum gonadotropin, the product was protected
from light and was only reconstituted with distilled, sterile water immediately prior to use.
Ovagen ™ (ICP, NZ Pat 220169) is a follicle stimulating hormone preparation produced from
ovine pituitary glands and freeze-dried immediately following purification to protect its potency.
Each vial contains the equivalent of 18 mg *NIADDK-oFSH-17 ovine pituitary FSH (1 mg
NIADDK-oFSH-17 is 20 units **NIH-FSH-S1). Each vial ofOvagen TM was reconstituted with
20 mL of sterile isotonic saline diluent immediately prior to use. A total of 10 mL of Ovagen™
alone or in combination with a single PMSG dose was injected intramuscularly (8 or 10 mL), in
a four-day period, injected twice daily. Protected from sunlight, the PMSG reconstituted
solution was used once, and any partially used vials were destroyed.
* National Institute of Arthritis, Diabetes and Digestive and Kidney Diseases, USA Ovine
Pituitary FSH Standards.
**National Institute of Health
Embryo-S (Jurox, Aus. Pat. 601421) is a purified ovine FSH, lyophilized to maintain its
potency under normal storage conditions (below 25 degrees). Embryo-S was available in two
sizes: one size contained 25 units NIH-FSH-S1 with 10 mL of sterile diluent each, and the
second contained 50 units NIH-FSH-S 1 with 20 mL of sterile diluent. The sterile isotonic saline
diluent contains sodium chloride solution. Once reconstituted, the solution was immediately
used or stored at 2 - 8°C and any unused solution was discarded after four days. Embryo-S was
used either as 1) 8 to10 mL (25 units) by intramuscular injection given in a single dose or
fractioned in 8 doses of 1.25 mL every 12 hours during 4 days, in combination with 300 or 400
ru of PMSG, 48 or 72 hours prior to the progestagen removal or 2) 10 mL fractioned in 8 doses
were given without PMSG.
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5.2.2 SUPEROVULATION TREATMENTS
Goats (n=367) were assigned to four different superovulation treatments (SUPOV -T) using 2
different products, Ovagen and Embryo-S. Each of these products was either used alone (E-S
alone or Ov alone) or in combination with PMSG (E-S + PMSG or Ov + PMSG) as shown in
Table 5-3.
Table 5-3 Summary of different Superovulation (Supov) treatments used during the experiment
Supov* Supov* Dosage & administration Associated with Symbol used No of
group drug goats
1 Ovagen 9 mg i.m. every 12 h, 8 None OValone 147
times, starting 72 h prior to
implant removal.
2 Ovagen 9 mg i.m. every 12 h, 8 PMSG 300m OV+PMSG 164
times starting 72 h prior to i.m., once 48 to
implant removal. 72 h prior
implant removal.
3 Embryo-S 25 units i.m. twice a day, 1 None E-S alone 16
or 8 times, 72 h prior
implant removal.
4 Embryo-S 25 units i.m. twice a day, 1 PMSG 300m E-S + PMSG 40
or 8 times, 72 h prior to i.m., once 48 h to
implant removal. 72 h prior to
implant removal.
* Supov = Superovulation
5.3 FERTILIZATION
5.3.1 NATURAL SERVICE
Most of the does were naturally bred during this study. Because does mated more than once are
more likely to conceive than those mated only once, they were introduced in the buck pen twice
a day (morning and evening) for three days. The first attempt at mating was performed 12 hours
after the progestagen withdrawal. Only one buck was ascribed to a particular doe during the 3
days of mating. In some cases, the does were left in the buck pen overnight from the second to
the third day and removed the following morning.
5.3.2 ARTIFICIAL INSEMINATION
5.3.2.1 Semen collection
The collection of semen by artificial vagina (AV) was the method of choice, since the technique
was successful in most of the trained bucks and representative ejaculates were obtained.
Alternatively, the electro-ejaculator was sometimes used in untrained males or those that refused
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to serve the artificial vagina. The AV consists of a stiff plastic tube casing about 15 cm long and
7 cm in diameter, with an air/water-filling valve in its wall. A cylindrical synthetic latex sleeve
of about 20 cm long and about 5 cm diameter was located inside the tube and both ends of the
rubber sleeve folded over the ends of the tube. The space between the tube and the rubber sleeve
was then filled with water at about 55°C until the space was almost full. The inner wall of the
rubber sleeve was lubricated on one side with a non-toxic sterile gel. In order to create
appropriate pressure during the simulated copulation, the space between the tube and the
synthetic rubber sleeve was further filled with water and air through the valve until the inner
lumen of the artificial vagina was occluded, allowing only one finger to be inserted. The inner
lumen temperature was monitored to an optimal temperature of 40 to 45°C. A synthetic rubber
cone with an attached glass tube was placed over the non-lubricated end to channel the semen
into the tube for collection. In order to prevent the spermatozoa from cold temperature shock,
the semen collection tube was covered with the palm of the hand.
The semen collection with the AV was made during attempts by a given buck to breed a
superovulated doe in which estrous behaviour was observed after progestagen withdrawal. An
assistant was needed to hold the doe in position while the semen was being collected. The
collection site had enough space for freedom of movement for the buck, the assistant, and semen
collector. Prior to the collection, dirt and debris were gently removed from the buck's prepucial
orifice by means of a sterile paper towel. The collector then knelt laterally to the doe's
hindquarters, on the same side of the doe as the hand holding the artificial vagina. The buck was
led to the doe's hindquarters where, in first response, he sniffed the perineal region and began to
protrude his penis, then mounted by grasping the doe's hindquarters and began short pelvic
thrusts in attempts to bring the extended penis into contact with the vulva. During these
attempts, the collector gently grasped the prepuce and diverted the tip of the penis into contact
with the artificial vagina. Ejaculation occurred with pronounced pelvic thrusts, while the
collector still held the AV at the prepucial orifice as the buck dismounted. The AV was held at
an angle downwards towards the glass tube to allow the ejaculated semen to flow into the tube.
After semen collection, the buck and doe were separated in order to avoid any reinitiated
breeding attempts.
An artificial vagina is preferable to the others methods of collection if time can be afforded for
the initial training period, which may occupy several weeks. This was not the case with bucks in
this study as they were accustomed only to free natural service. Consequently, the inability or
unwillingness of certain bucks to use the AV forced us to use the electro-ejaculation methods, in
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order to save time. The electro-ejaculator apparatus used consisted of a stimulator powered by
batteries connected to a probe via conductor wires. An assistant restrained the buck either in
standing or in lateral recumbence. The probe was then introduced in the buck's rectum with the
electrodes positioned toward the pelvic floor by a second assistant while the semen collector was
manually holding the shaft of the penis (cleaned with a paper towel) inserted in a dry, clean
plastic collection tube. A rhythmic and increasingly intensified application of electric current
was administered, with the current on for 2 to 3 seconds and off for 2 to 3 seconds. The
extension of the penis followed by ejaculation was the expected reaction.
5.3.2.2 Semen evaluation
Visual assessment of the motility of spermatozoa is one of the most rapid and widely used tests
of semen quality. It is the one that was used during this study. The semen sample was kept
warm (35 to 38°C) in order to avoid any temperature shock, and motility was assessed
immediately after collection. A drop of semen was placed on a warmed slide and examined
under a microscope at low magnification (X10 objective). The wave motion was assessed in a
system where the absence of wave indicated bad semen with motionless spermatozoa, and dense,
rapidly moving waves signified good semen with 90% or more spermatozoa being alive and
active.
5.3.2.3 Semen dilution
Semen diluents provide some nutrient for the metabolic processes of the sperm, creates pH
stability, protect against the cold shock, and also make possible the extension of the volume of
semen to allow many females to be inseminated. A variety of extenders have been utilized to
dilute ram and buck semen for use in the short or long term. Most semen diluents utilize egg
yolk or milk as the basic ingredient, which protects the spermatozoa against the cold shock by
the presence of the lipoprotein and lecithin in the yolk and the casein in the milk. While both
egg yolk and milk can be used in sheep semen, only skimmed and ultra heat-treated fat-free milk
should be used to extend goat semen. Indeed, the presence of phosphotidase in the seminal
plasma of goats catalyses the hydrolysis of lecithin in egg yolk into fatty acid and lysolecithins,
which are toxic to the spermatozoa. Otherwise, for goats, diluents with a low concentration of
egg yolk (~1.5%) can be used, or the seminal plasma, containing phosphotidase, should be
removed by centrifugation and washing (Wallace, 1992)
In this experiment, however, the dilution of the semen was made with fat free ultra high
temperature treated (UHT) milk at the rate of 1:4. Therefore with about 1 mL semen collected
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per ejaculate, we would add 4 mL ofUHT milk to make 5 mL of the extended semen that would
serve up to 20 does at the dose of 0.25 mL per doe. The refrigerated milk was warmed in hot
water to 38-40°C before diluting the collected semen. The extended semen was kept in warm
water (around 35°C) contained in a polystyrene box, and the temperature was closely monitored
with a thermometer, during the insemination process.
5.3.2.4 Insemination procedure
Artificial insemination was only used in one site (at the AES station) during the experiment.
Cervical insemination was the method used. A pre-warmed insemination pipette, or a catheter
attached to the syringe was loaded with about 0.25 mL of semen and made ready for
introduction into the cervix. The assistant restrained the doe with her hind legs lifted over a 60
to 80 cm high bar. When the doe was in position, the vagina was wiped clean using tissue
paper. A lubricated speculum was then inserted into the vagina and the cervix brought into view
with the aid of a headlamp. The catheter or pipette, protected from the cold shock, in a sterile
plastic sleeve covered by a clean cloth, was released from there and the tip was introduced
gently with one hand about 1 cm, and the plunger was slowly depressed to release 0.25 mL of
semen into the cervix (see Fig. 5-3).
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Fig 5-2 Cervical insemination in goats
Uterine Body
;;;;~~~::::....:::-~~- (site of semen
delivery)
Speculum
Fig 5-3 Cervical insemination technique in goats (cross sectional view)
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5.4 EMBRYO RECOVERY
5.4.1 MEDIA USED FOR EMBRYO COLLECTION
Medium type and quality is a critical factor in an ET program. The medium must be free of any
contamination and should be sufficient to maintain embryo viability. Dulbeccos Phosphate
buffered saline (D-PBS) was the medium used during this study in the embryo collection,
storage, micromanipulation, and freezing process.
5.4.1.1 Media mixing
PBS used was purchased as a pre-weighed powder. The calcium chloride for powdered D-PBS
was supplied in a separate packet. Powdered D-PBS was first dissolved in double-distilled water
contained in a flask. Then the calcium chloride, dissolved separately in double distilled water,
was added to the former solution after the contents of the first packet were completely dissolved.
Failure to completely dissolve the powder from the first packet prior to adding the calcium
chloride would cause the formation of a precipitate. After all the powder was dissolved, the
medium was generally used at once. One packet of D-PBS was used in every 1000 mL of
double-distilled water.
5.4.1.2 Macromolecules and antibiotics
Lyophilized newborn calf serum to which antibiotics (100 iu of penicillin and 100llg of
streptomycin per mL of mixed solution) were added, was used in collection and holding media
as a macromolecule. The main function of the calf serum was to coat plastic and glassware to
keep the embryos from sticking to them due to surface tension and electrical polarity. After any
protein (serum or bovine serum albumin) is added to D-PBS, it becomes an excellent growth
medium for bacteria and other microorganisms. For that reason, protein combined with
antibiotic was added just prior to use in a proportion of 1% (10 mL of protein for 1000 mL of the
medium) for the collection medium. Unused medium containing protein was not stored longer
than 24 hours in the refrigerator.
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In summary, the following were used for the collection medium:
1) I litre phosphate buffered saline (PBS)
2) 100,000 ru penicillin
3) 100,000 ru streptomycin
4) 10 mL calf serum (1%)
5.4.2 EMBRYO COLLECTION TECHNIQUE
The surgical laparoscopic method was used during this experiment. The procedure was
essentially equivalent to a surgical uterine flush, except that all manipulations of the
reproductive tract, during the checking of CL numbers, were carried out with the aid of grasping
forceps, and fine trochars were used. However, exteriorization of the tract at laparotomy, for the
purpose of embryo collection, inevitably involved some degree of surgical trauma, and often
leads to the formation of post-operative adhesions involving the uterus and ovaries. The
following steps were taken:
5.4.2.1 Anaesthesia
Food and water were withheld 24 to 36 hours prior to the embryo collection of the animals. To
facilitate manipulation of the animal, general anaesthesia was used. Anaesthesia was induced by
injecting about 15 to 25 mg of thiopentone sodium (Intraval Sodium, Rhone Poulenc) per kg of
body mass in the vena jugularis in the neck region (1 gIntraval Sodium dissolved in 20 mL
water would anaesthetized a 70-kg doe). Thiopentone sodium is a short-acting barbiturate
employed as a general anaesthetic for short surgical procedures, or in this case as a basal
anaesthetic before the use of inhalation.
An endotracheal tube was placed through the pharynx and larynx into the trachea with the aid of
a curved stainless steel rod. The rod was removed, the cuff inflated with about 20 mL of air, and
the air inlet valve closed. This was done to prevent any pharyngeal contents that could possibly
be vomited during anaesthesia from entering the lungs and to keep the tracheal tube in position.
The tube was taped to the mouth with masking tape to secure the tube position. The doe was
then placed in a specially designed cradle on its back with legs securely tied to the cradle bars
over the Achilles tendons. The cradle was made so that it could be inclined at an angle of about
30 to 45°C to the horizontal. Then the end of the Y-piece of a fluothane anaesthetic machine
was connected to the endotracheal tube, and the gas (fluothane) setting put at around 2%. The
fluothane (Halotane, ICI) gas was then increase to 3% or 4% depending on the need of the
animal. Oxygen flowed through the system at a rate of about 0.5 litre per minute. After
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restraining the animal on a surgical table in dorsal recumbency, the head was held down at a
45% angle to the horizontal so that the hindquarters were above the head. The abdominal area
anterior to the udder was shaved, washed and disinfected.
5.4.2.2 Surgery
Three stab incisions were made approximately 3 to 4 cm on either side of the mid-line. The first
was 25 cm anterior to the udder for the laparoscope, the second was about 15 cm anterior to the
udder for the insertion of the uterine grasping forceps. Prior to the insertion of the laparoscope
the peritoneal cavity was insufflated with approximately 4-5 litres of air. After establishment of
the pneumoperitoneum (insufflation of the abdominal cavity), the laparoscope was inserted, the
uterus and ovaries located, and ovarian response was recorded by counting the number of
corpora lutea. While viewing the uterus through the laparoscope, the tip of the hom of the uterus
was grasped with Allis tissue forceps and exteriorized through a mid-ventral line incision (5-10
cm). The incision was made cranial to the udder attachment to allow elevation of each side of
the uterus body and hom. The forefingers of the right hand were inserted into the abdominal
cavity and directed downwards and backward to locate the uterus, which was recognized by its
firm horns and pink color. The uterus was withdrawn from the abdominal cavity. From then on,
the uterus was kept wet with a saline-heparin-antibiotics solution. The reproductive tract was
flushed with D-PBS as already described.
5.4.2.3 Flushing
Uterine flushing was the technique used for embryo-collection (Fig. 5-4 and 5-5). A puncture
wound was made into one uterine hom at the uterine bifurcation (1), using a pair of closed artery
forceps. The hole made was slightly widened by opening the end of the forceps in the hole. A
special glass cannula, 25-30 cm long with a double bend, was inserted into the uterine lumen
through the puncture to a depth of between 2 to 5 cm and tightly held in that position by means
of a grasping modified bowl clamp. A 20-mL syringe (4) fitted with a 20 to 22 G plastic IV
catheter was inserted at the utero-tubal junction (3). The needle supporting the catheter during
the insertion was removed. Twenty millimeters of flushing media was injected through the IV
catheter, while the assistant was massaging the tip of the uterine hom, and out through the glass
cannula. The flushings (flushed media) were collected into a small bowl (glass beaker) (5-5).
Occasionally, the fluid did not flow readily and checks were then made to ensure that the
catheter and glass cannula were in good position. The syringe was withdrawn and the fluid
pressed gently towards the uterine body so that as much flushed medium as possible was
collected into the bowl. The glass cannula was then removed from the uterine hom
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Fig. 5-4 Embryo flushing technique using glass catheter
1 - Insertion point to Foley catheter
2 - Foley catheter
3 - Insertion point for flushing needle
4 - Syringe with flushing medium
5 - Embryo collection vessel
Fig. 5-5 Embryo flushing technique using Foley catheter
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and the fluid in it allowed to run into the bowl or into sterile petri dishes for immediate
examination and counting under a dissecting microscope by another technician. Then the other
uterine hom was treated in a similar manner. As a rosette of endometrium protruded from the
puncture wound after catheter removal, this was always closed with an inverted horistal mattress
suture, using atraumatic needles and fine catgut. The reproductive tract was irrigated with warm
saline, and returned to the abdominal cavity.
Care was taken throughout the surgery to minimize postoperative development of abdominal
adhesions. To prevent this problem, 50-100 mL of a solution of 5% dextrose with heparine and
gentomycin was dripped into the peritoneal cavity before closure. The peritoneum (and the body
wall sutured together) and muscles layers were closed by continuous polyglycolic acid suture.
5.4.2.4 Post-surgery
The skin incision was closed with interrupted sutures. The wound was sprayed with wound
aerosol. The doe received an injection of 5 mL long acting penicillin. The anaesthetic machine
was removed from the endotracheal tube. The doe was placed upright on its sternum, the cuff of
the tube deflated and the endotracheal tube removed from the trachea. The doe was allowed to
recover quietly from the anaesthetic in a well-bedded room.
5.4.3 ISOLATION OF EMBRYOS
In both cows and goats the method used for isolation of embryos is essentially similar. The
filtration method of isolating embryos was used in this study. Flush fluid collected in a glass
beaker was poured through the filter unit (Emcon filter) and was allowed to escape through a
short length of tubing. The outflow was controlled by means of a clamp. To prevent
dehydration of the embryos at least 1 cm of the medium was retained in the filter to cover the
filter grid on which the embryos rested. To recover the embryos from the filter, the filter was
swirled and the content was poured into a searching dish. Immediately after, the filter was
quickly rinsed in concentric circles while holding it partly inverted, moving from the outer rim
of the grid to the centre, using a 22 G needle mounted on a 50 mL syringe containing flushing
medium without serum or bovine serum albumin (BSA). The omission of protein from the
medium for this step was important to prevent foaming when it was ejected from the needle,
since embryos are easily lost among the bubbles, which can persist for hours. The sides of the
filter and the grid were rinsed several times until all vestiges of mucus and cellular debris was
gone. This took considerable rinsing at high pressure.
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Medium containing 10 % calf serum was added to the searching dish after the filter was
thoroughly rinsed to keep embryos from sticking to the dish or pipette and also serving as a
nutrient medium. The flush fluid was examined systematically at about XIO to XIS
magnifications to locate embryos and isolate them. A fine pipette was used to move them into
fresh medium. The pipette was made from Pyrex glass tubing, with a 4 mm outside diameter. A
15 cm length glass of tubing was heated in the center with a Bunsen burner, and pulled to make
an outside diameter of less than 1 mm. This was then scored with a diamond pencil and broken
to make two pipettes. All ends were fire-polished. After pipettes had been washed and rinsed
thoroughly, they were placed in clean glass test tubes with screw tops and sterilized (and dried)
by dry heat. For use, pipettes were connected to a 0.5 or I mL syringe or plastic mouthpiece
with rubber tubing. Embryos recovered were transferred to fresh holding medium (PBS
containing 10 % calf serum) when they were found. As far as labor was available, two people
examined each dish twice. Dishes that were not being examined were covered and stored where
they would not be exposed to excessive light. As soon as all embryos were located, they were
evaluated and immediately prepared for cryopreservation.
5.5 EVALUATION OF EMBRYOS
The procedure for classifying the embryos consisted of isolating them; removing debris (which
occurred in the process of washing them); and then separating them into 2 main groups of I)
Transferable (or freezable), and 2) Non-transferable (Unfertilized Oocyte or UFO, severely
degenerated, and early stage embryos).
Evaluation of embryos was done as described by Seidel & Seidel (1991) (Fig. 5-6) at X50 to
XI00 magnification under a stereoscopic microscope, with the embryos in the 4 well culture
dish. Each embryo or ovum was then carefully examined individually by focusing up and down
and in certain cases rolling the embryo with a pipette or by swirling the dish. Embryos that were
of doubtful quality were discarded. Retarded embryos at the time of collection (4, 8 cell-
embryos) were equally discarded. In our laboratory, two criteria were taken in account for the
classification of embryos including the stage of its development (as adapted from Table 4-1) and
its quality or health status.
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Fig. 5-6 Stage of embryo development (Seidel & Seidel, 1991)
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5.5.1 EMBRYO STAGE
In term of this study, we called
• Morula (M) a mass of at least 16 cells. Individual blastomeres are difficult to discern
from one another after compaction. The cellular mass of the embryo occupies most of
the space within the zona pellucida.
• The expression compact morula (CM) was individual blastomeres that have joined
together, forming a compact mass. The embryo occupies 60 to 70 % space within the
zona pellucida.
• Early blastocyst (EB) was used to describe an embryo that has formed a fluid-filled
cavity or blastocoele and gives a general appearance of a signet ring. The embryo
occupies 70 to 80 per cent of space within the zona pellucida. Early in this stage the
embryo may appear of very questionable quality.
• Blastocyst (B) was characterized by a pronounced and evident differentiation of the
outer trophoblast layer and the darker, more compact inner cell mass. The blastocoele is
highly prominent, with the embryo occupying most of the perivitelline space. Visual
differentiation between the trophoblast and the inner cell mass is possible at this stage of
development.
• In the expanded blastocyst (XB), the overall diameter of the embryo dramatically
increases, with a concurrent thinning of the zona pellucida to approximately a third of its
original thickness.
• Hatched blastocyst (HB) was an embryo recovered at the stage in which it undergoes
the process of hatching or may have completely shed the zona pellucida. Hatched
blastocysts may be spherical with a well-defined blastocoele or may be collapsed.
Identification of embryos at this stage can be difficult for the inexperienced operator.
Embryos collected for transfer purposes in this study ranged from morula through
expanded blastocysts.
5.5.2 EMBRYO QUALITY
• Grade 1 or excellent was an ideal embryo, spherical, symmetrical and with cells of
uniform size, color and texture. Less than 5 % of the blastomeres are visually abnormal.
• Grade 2 or good was characterized by small imperfections such as a few extruded
blastomeres, irregular shape and a few vesicles. Between 5 and 25 % of the blastomeres
are visually abnormal.
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• Grade 3 or fair were embryos with more definite problems including presence of
numerous extruded blastomeres, vesiculation and a few vesicles. More then 25 % of the
blastomeres are visually abnormal.
• Grade 4 or Poor was embryos with severe problems, numerous extruded blastomeres,
degenerated cells, cells of varying sizes, large numerous vesicles but no apparently
viable embryo mass. Also included in this category were all the unfertilized oocytes.
In this study, Grade 1 and 2 were considered as transferable embryos, and Grade 3 and Grade 4
were rejected as non-transferable.
5.6 STATISTICAL METHODS AND CONSIDERATIONS
5.6.1 STATISTICAL DESIGN OF THE STUDY
Table 5-4 Summary of the design of the superovulation and synchronization program of this
study
Synchronization Synchronization Treatments Total CL Total Eggs *Transf UFOs
Products (Synch-P) (Synch-T) (Means) (Means) Embryos (Means)
(Means)
1 5MB 1 5MB one dose
2 5MB two doses
2 CIDR 3 CIDR one dose
4 CIDR two doses
Superovulation- Superovulation-Treatments Total CL Total Eggs *Transf UFOs
Products (SupOv-P) (SupOv-T) (Means) (Means) Embryos (Means)
(Means)
1 Ovagen 1 Ovagen alone
2 Ovagen + PMSG
2 Embryo-S 3 Embryo-S alone
4 Embryo-S + PMSG
As shown in Table 5-4, the design of this study, in accordance with the objective stated in the
introduction, was to assess different superovulation and synchronization treatments in the Boer
goat. In exploring the different treatments used, this study attempted to determine the efficiency
of the different products used during these experiments namely two superovulation products
(Supov-P), Ovagen and Embryo-S; and two synchronization products (Synch-P), 5MB and
CIDRs, used during the experiments, through their effects on ovulation rate, and fertilization rate
of the South African Boer goat (See first column of Table 5-4).
In summary, the study has evaluated and compared four different synchronization treatments
(Synch- T) consisting of:
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1) One dose of 5MB (SMB xl)
2) Two doses of 5MB (SMB x 2)
3) One dose ofCIDR (CIDR x 1)
4) Two doses ofCIDR (CIDR x 2) (see second column of Table 5-4.) and;
Four superovulation treatments (Supov- T) consisting of
1) Ovagen alone
2) Ovagen associated with PMSG
3) Embryo-S alone
4) Embryo-S associated with PMSG
Because these different treatments took place in diverse locations, environmental conditions
shaping the body condition, seasons, and ages of animals, as well as the use of ECP (Estradiol
Cypionate), we investigated to what extent these additional factors can impact the different
results obtained.
Independent variables (factors) analyzed in this study were:
1) Superovulation treatments (four groups as shown in Table 5-3)
2) Synchronization treatments (four groups as indicated in Table 5-1)
3) Use or no ofECP (two groups as described in Table 5-2)
4) Age was divided in four groups (1 = one year, 2 = 2 years, 3 = 3 years, 4 = 4 years and
up)
5) Body condition was divided in four groups (1 = poor, 2 = fair, 3 = good, and 4 =
excellent)
6) Season was divided in two groups (1 for low fertility in spring and summer and 2 for
high fertility in fall and winter.)
Dependent variables in this study included the:
1) Total number (left and right ovary) of corpora lutea (TOT_CL),
2) Total number (embryos plus ova) of eggs (TOT_EGGS),
3) Number of transferable embryos (TransEmb),
4) Number of unfertilized oocytes (UFOs.)
The data from seven does were excluded from the data analysis. Two of them did not stand
during the service, suggesting they have not come into estrus. Two more were sick and in very
bad physical condition. Two had early pregnancies, and one of them had massive uterine
adhesions.
43
Stellenbosch University http://scholar.sun.ac.za
5.6.2 STATISTICAL METHODS
The data were analyzed using the SAS system (SAS Institute, Cary, NC, USA). Descriptive
statistics were obtained for each treatment group (superovulation and synchronization
treatments) and other covariates (location, season, use of estradiol, age and body condition).
Because the data were not normally distributed and log- or square root transformations were not
effective in achieving normality, the data were analyzed as follows. First, the statistical
significance of the relationship between each of the dependent variables (total number of corpora
lute a, total number of eggs, number of transferable embryos and number of unfertilized oocytes)
and the independent variables (superovulation and synchronization treatments, location, season,
use of estradiol, age and body condition score) were assessed using nonparametrie tests i.e.,
Wilcoxon test for binary variables and Kruskal- Wallis test for polytomous variables (Siegel &
Castellan, 1988). Each outcome variable was then modeled using the Mixed Procedure of SAS
to determine the significance of the differences between treatment groups in models adjusted for
other covariates. Because of lack of normality in the dependent variables and because of some
variation due to location and season, the models were fit using the Empirical option in proe
mixed and treating location and season as random effects in the models. This approach uses the
sandwich estimator for variances of fixed effects and is robust where the data are not normally
distributed. The significance of the differences in the least squares means for the main effects
were tested using the Tukey test. Differences were considered significant at p<O.05.
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CHAPTER6
RESULTS, DISCUSSION AND CONCLUSION
6.1 OVERALL RESULTS
Basic descriptive statistics (Table 6-1) show a mean ovulation rate (average number of eggs shed
per superovulation = total eggs shed / number of goats superovulated) of 10.35 ± 0.39 per donor.
The proportion of animal that produced a number of CL equal or higher than one by the total of
animal treated was 87.46 %. Four or less CL were counted in 22.62 % of superovlated does
while 77.38 % of them produced above or equal to five CL. The mean ovulation in this latter
group was 13 CL, with a higher mean (15.4) from the superovulation treatment group using
Ovagen alone (Table 6-2). On the other hand, the group that produced CL ~ 4, had mean
ovulation of 1.1 with the lowest mean (0.9) in the Ovagen alone group.
Table 6-1 Ovulation response and egg/embryo collection
Number of Min Max Mean Standard Error of
Standard of
does Mean Deviation
TOT CL 367 0 34 10.35 0.39 7.43
TOT EGGS 367 0 39 7.92 0.43 8.40
TRANSEMB 367 0 38 4.64 0.36 6.99
UFOS 367 0 31 2.86 0.28 5.34
TOT_ CL= Total number of corpura lutea; Tot-Eggs = Total number of eggs; TransEmb = Number of transferable embryos; UFOs = Number of
unfertilized oocytes.
The recovery rate, obtained by dividing the total number of eggs (ova and embryos recovered)
by the total number of CL, performed was 76.5%. The conception rate is the proportion of
animals mated that conceived. In this study, the conception rate has been expressed as the
number of does with more than one transferable embryo divided by the total number of does
mated and was 50 %.
This study revealed in general a slightly higher number of CL on the left ovary (52%) than on
the right ovary (48%). This was consistent for most variables measured (age, body condition,
season, synchronization treatment, superovulation group), except in animals of poor body
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condition (BCS = 1), those where Embryo-S + PMSG were used, and those where two doses of
5MB were used.
5.30 +--------j
4.80 +---_....-"-----'--------~
Fig. 6-1 Corpora Lutea produced on the left and right side of the Boer goat ovary
Table 6-2 Distribution of ovulation rate following different superovulation treatments
====---- Superovulation Number of Doe Mean ovulation % of all treatedTreatment treated per doe animalsCL equal to or Ovagen alone 28 0.9
below 4 Ovagen + PMSG 35 0.9
Embryo-S alone 5 3.0
Embryo-S + PMSG 15 1.6
Total CL:S:4 83 1.1 22.62 %
CL equal to or Ovagen alone 119 15.4
above 5 Ovagen + PMSG 129 11.8
Embryo-S alone 11 10.0
Embryo-S + PMSG 25 9.6
Total CL ~ 5 284 13.0 77.38 %
Total CL all does 367 10.4 100%
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6.2 EFFECTS OF DIFFERENT FACTORS ON OVULATION AND
EGGlEMBRYO COLLECTION
Effects of season on ovulation and egg/embryo recovery6.2.1
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TOT _CL= Total number of corpura lutea; Tot-Eggs = Total number of eggs; Trans-Emb = Number of transferable embryos; UFOs = unfertilized
oocytes.
Fig. 6-2 Effects of season based on observed means
As shown in Fig. 6-2, the means of total number of CL, total number of eggs and transferable
embryos were higher in fall and winter than in spring and summer except for the number of
unfertilized oocytes. However, the univariate analyses demonstrated significant difference
(p<O.05) only for the number of transferable embryos and the number unfertilized oocytes.
6.2.2 Effects of location on ovulation and egg /embryo recovery
The average number of total eggs (ova and embryos), as shown on Fig. 6-3, has been
demonstrated by the non-parametric one-way test (Wilcoxon) to be significantly different in
regards to the location. There was significantly higher number of eggs (p<O.05) recovered in the
Grootfontein Agricultural College Embryo Station (GACES) in Middleburg than in the African
Embryos and Semen location (AES) in Stellenbosch. In addition, the number of unfertilized
oocytes collected was more in the GACES location than AES location, although not
significantly so (p>O.05).
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Fig. 6-3 Effects of location based on observed means
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Fig. 6-4 Effects of age based on observed means
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TOT _CL= Total number of corpura lutea; Tot-Eggs = Total number of eggs; Trans-Emb = Number of transferable embryos; UFOs =
unfertilized oocytes.
Fig. 6-5 Effects of body condition based on observed means
Figures 6-4 and 6-5 show the effects of age and body condition on ovulation and egg/embryo
recovery based on observed means. No significant univariate association (p>O.05) was detected
for age and body condition. Likewise, in the multivariate model adjusted for age and body
condition, among other main effects, these two factors didn't show any significant differences
(p>O.05).
6.2.4 Effects of the use of estradiol cypionate (ECP) on ovulation and egg/embryo recovery
Figure 6-6 represents the effects of using ECP in superovulation treatment on ovulation and
egg/embryo recovery based on observed means. Generally, more eggs/embryos were recovered
from ECP-used than no ECP group except for UFOs. There was a significant univariate
association (p<O.05) between the use of estradiol cypionate and the number of transferable
embryos, and a marginal association (p=O.08) between the ECP use and the number of
unfertilized oocytes. The association between ECP use and the number of total CL and eggs
recovered were not significant (p>O.05). On the other hand, the multivariate analyses in the
models in which ECP use was adjusted as main effects, no significant association (p>O.05) was
shown.
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6.2.5 Effects of synchronization treatment on ovulation and egg/embryo recovery
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Fig. 6-7 Effects of synchronization based on observed means
Figure 6-7 shows the effects of synchronization treatment on ovulation and egg/embryo recovery
based on observed means. Transferable embryos and unfertilized oocytes were significantly
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associated (p<O.05) with the estrous synchonization treatment in univariate analysis. The
multivariate analysis showed a marginal association between synchronization and the number of
CL, transferable embryos and unfertilized oocyte.
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Fig. 6-8 Effects of synchronization treatments on ovulation and egg/embryo recovery based on
the Estimated Means (LSM*)
Figure 6-8 and Table 6-3 portray the results obtained in the multivariate model adjusted for
synchronization, superovulation, age, and body condition score as main effects and location and
season as random effects. In this model, with the total number of CL as a dependant variable,
synchronization treatment was marginally significant (p=O.06) as main effect. In a post-
ANDVA analysis using Tukey multiple comparison test, only the use of two doses of CIDR
(CIDR x 2) was significantly (p=O.OO1) different from the use of two doses of 5MB (SMB x 2),
while the others treatments were not significant difference (p>O.05).
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Table 6-3 Ovulatory response and egg/embryo recovery following different synchronization
treatments in Boer goats (LSM* ± SEM**)
Synchronization No of No of No of No of No of
treatment Animals CL Eggs Transferable embryos UFOs
1. 5MB xl 123 9.28 ± 0.71 ab 7.09±0.79a 4.83 ± 0.67a 1.99 ± 0.43 a
2. 5MB x2 32 6.39 ± 1.46 b 3.88 ± 1.66a 3.66± 1.41 a 0.32 ± 0.94 a
3. CIDR xl 187 8.52 ± 0.88 ab 6.65 ± 1.13 a 3.02 ± 0.86 a 3.47 ± 0.58 a
4. CIDRx2 25 12.19 ± 1.59 a 9.86 ± 2.22 a 7.23 ± 1.96a 1.68 ± 1.07 a
Values in columns with different superscripts are significantly different. P :<; 0.05
* LSM = Least square means or estimated means
**SEM = Standard error of means
In a similar model, there was no significant multivariate association between synchronization
and the total number of eggs recovered and the number oftransferable embryos. However, in the
model for unfertilized oocytes, synchronization treatment was significant (p>O.05) as a main
effect but no significant differences were detected between different treatment groups in the post
ANDY A analysis.
6.2.6 Effects of superovulation treatment on ovulation and egg/embryo recovery
Figure 6-9 below shows the effects of superovulation on ovulation and egg/embryo recovery
based on observed means. Overall, there was a strong univariate association (p<O.05) between
superovulation treatment and the total number of CL, and the total number of unfertilized
oocytes. The multivariate model (Fig. 6-9) strongly corroborates this association.
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Fig. 6-9 Effects of superovulation treatments based on observed means
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Fig. 6-10 Effects of superovulation treatments on ovulation and egg/embryo recovery based on
the Estimated Means (LSM*)
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Figure 6-10 and Table 6-4 depict the results obtained in multivariate analysis adjusted for
superovulation, synchronization, ECP use, body condition score and age as main effects, and
location and season as random effects. In this model, with the total number of CL as a
dependant variable, superovulation treatment was significant (p=O.OOOl)as main effect. In a
post-ANOVA analysis using Tukey multiple comparison test, treatment 1 consisting of the use
of Ovagen alone was significantly (p<O.05) different from treatment 3 (Embryo-S alone) and
treatment 4 (Embryo-S + PMSG). In other words, higher number of corpora lutea were detected
in the treatment group were Ovagen alone was used than in the treatment groups which used
Embryo-S alone and Embryo-S + PMSG. Also, Ovagen + PMSG treatment group produced
significantly higher number of CL (p<O.05) than Embryo-S + PMSG, while the number of
corpora lutea in Ovagen alone group were marginally higher (p=O.06) than in Ovagen + PMSG
group.
Table 6-4 Ovulatory response and egg/embryo recovery following different superovulation
treatments in Boergoat (LSM* ± SEM**)
No of No of No of No of No of
Superovulation Treatments Animals CL Eggs Transferable embryos UFOs
1. Ovagen alone 147 12.85 ± 0.74 a 8.83 ± 0.99ab 5.66 ± 0.80 ab 2.85 ± 0.63 a
2. Ovagen + PMSG 164 9.55 ± 1.11 ab 9.47 ± 0.41 a 6.28 ± 1.15 a 2.46 ± 0.84 ab
3. Embryo-S alone 16 7.78 ± 1.61 b 4.04 ± 1.87 ab 3.59 ± 1.61 ab 0.70 ± 0.71 b
4. Embryo-S + PMSG 40 6.20 ± 1.29 b 5.14 ± 1.47 b 3.21 ± 1.29 b 1.43±0.78ab
Values in columns with different superscripts (except between treatments 2 and 3) are significantly different. P::; 0.05
*LSM = Least square means or estimated means
**SEM = Standard error of means
In a similar model using the total number of eggs as dependant variable, only superovulation
treatment was significant as main effect. However, in the post-ANOV A analysis, only Ovagen +
PMSG treatment group produced significantly higher total number of eggs (p=O.01) than
Embryo-S + PMSG group. For transferable embryos, superovulation was significant (p=O.02) as
main effect. In the post-ANOV A analysis, only superovulation treatment using Ovagen +
PMSG was significantly different (p=O.02) from treatment using Embryo-S + PMSG. In the
model for unfertilized oocytes superovulation treatment was again significant (p<O.05) as a main
effect. Only Ovagen alone treatment group was found to be significantly different from
Embryo-S alone in the post-ANOV A analysis.
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6.2.7 Comparison between the two synchronization products (SMB and CIDR)
When the two synchronization products (SMB and CIDR) used during the experiment were
evaluated, there was a significant univariate association (p<O.05) between synchronization and
the number of transferable embryos. There were also significantly higher (p<O.05) transferable
embryos and less UFOs produced in the overall 5MB group than there was in the CIDR group
(Fig. 6-11). However, the multivariate analysis of the synchronization products used could not
back up that assertion while it demonstrated an evident significant difference between treatment
using two doses of CIDR over that using two doses of 5MB on corpura lutea production with the
CIDR leading.
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TOT _CL= Total number of corpura lutea; Tot-Eggs = Total number of eggs; Trans-Emb = Number of transferable embryos; UFOs =
unfertilized oocytes.
Fig. 6-11 Synchronization using 5MB vs CIDR based on observed means
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6.2.8 Comparison between the two superovulation products (Ovagen and Embryo-S)
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Fig. 6-12 Superovulation using Ovagen vs Embryo-S based on observed means
Generally Ovagen alone or in combination with PMSG gave higher number of eggs than the
Embryo-S alone or in combination with PMSG (Fig. 6-12). In assessing the two superovulation
products used, Ovagen and Embryo-S, there was significant association (p<O.05) between the
superovulation products used and the production of corpora luteum in univariate analysis.
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6.3 DISCUSSION AND CONCLUSION
The primary goal of superovulation is to obtain consistently high numbers of transferable
embryos. Successful techniques of estrous synchronization in a superovulation programme must
not only establish tight synchrony, but also provide an acceptable level of fertility upon AI and
natural breeding (Wideus, 1999). This study assessed synchronization and superovulation
treatments that could enhance ovulation rates, improve embryos quality (transferable embryos),
establish optimum doses of synchronization agents, and explore the possible benefits resulting
from a superovulation co-treatment with an additional agent.
The multivariate analysis of the effect of synchronization treatments on ovulation rate in this
study showed only a marginal association (p=0.06). In post ANOVA analysis, however, only
two doses of CIDR (CIDR x 2) were significantly associated (p<0.05) with a high ovulation rate
as compared to two doses of 5MB (SMB x 2). This was demonstrated by a higher number of
CL in CIDR x 2 than 5MB x 2.
Related studies comparing the two synchronization agents, CIDR and 5MB, in a design similar
to our investigation in Boer goats have, to our knowledge, not been done. However, several
comparisons among other synchronization agents are found in the literature, as is analysis of the
effect of synchronization treatments on ovulation rate. Our findings agree with the study by
Thompson et al. (1990) reported by Cognie (1999), which found that both ovulation rate and the
number of embryos of transferable quality (assessed on day 6) increased when ewes were
primed for 12 days with two consecutive (CIDR x 2) versus a single (CIDR x 1) controlled
internal drug release device (CIDR, containing 9 % progesterone.). But our study disagrees with
that same study in that the difference was not significant in our analysis. This might be due to
the different species between the two studies (does vs. ewes) or the nature of the data
commending different statistical analysis. However, the univariate analysis of our study
demonstrates a significant association between synchronization and the number of transferable
embryos and the number of UFOs, results consistent with a couple of studies reported by
Wallace (1992) in her report on recent progress in sheep and goat research, suggesting that
embryo quality was linked to progesterone priming at the time of superovulatory hormone
administration. One such study by Scudamore et al. (1991) - based on ewes primed and
synchronized to ovulate with the intravaginal pessary containing 30 or 40 m of synthetic
progestagen (fluorogestone acetate), superovulated with PMSG and GnRH, and then
inseminated at 48 h after pessary withdrawal - established that ovulation rate was not influenced
57
Stellenbosch University http://scholar.sun.ac.za
by the level of progestagen priming, a result consistent with our univariate analysis. These other
reported studies suggest that the level of progesterone I progestagen priming prior to
superovulation may be influencing follicle growth and development and/or the oviduct-uterine
environment by mechanisms as yet unknown (Wallace, 1992). Our study, however, shows no
significant difference in ovulation rate associated with the use of different doses for any
synchronization treatment used (CIDR or 5MB), findings consistent with the Scudamore et al.
(1991) study reported above.
The findings of our study may suggest the benefit of two doses of CIDR over two doses of 5MB,
though the study found no statistical evidence to substantiate that claim. Apart from a significant
difference between two doses of CIDR and two doses of 5MB on ovulation rate, our study
comparing CIDR to 5MB found no other significantly different (embryo quality) advantage
between the two synchronization products.
Other studies attempting to establish a connection between different synchronization dosages
and ovulation rate, embryo quality and pregnancy rate resulted in different outcomes. In a study
conducted in Mexico (Mellado & Valdez, 1997) trying to determined the minimal dose of
norgestomet (SMB) necessary to induce estrus in goats, and to examine the effect of new or
recycled norgestomet implants on goats, concluded that the effect of norgestomet dosage and
status of the implant (new or previously used in goats) had no significant effect on reproductive
performance (shown in the study by the absence of relationship between pregnancy rate and the
dose level of the norgestomet used). The same study concluded that one-fifth of the 5MB
implant (1.2 mg of norgestomet) used for cattle was sufficient to control estrus in the crossbreed
Criollo goats. The lowest dose effective for estrous synchronization in the above Mexican study
(1.2 mg of norgestomet) was less than half the dose reported successful for induction of estrus in
dairy goats (Bretzlaff & Madrid, 1985.) That latter dose was the minimum dose used in our
study in Boer goats (3 mg for 1 dose of 5MB). Another study from Brazil trying to determine
the efficiency of different protocols in inducing and synchronizing the estrous cycle of Saneen
goats by using new or reused 5MB and CIDR in combination with either PMSG or cloprostenol
concluded that auricular implants or intravaginal devices may be reused, at least one more time,
because they are efficient for inducing and synchronizing the estrus in the cyclic dairy goats
(Oliviera et al. 2001).
As for studies comparing the efficiency of different synchronization agents in the Boer goat, one
South African study conducted by Motlomelo et al. (2002) comparing the CIDR devices
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medroxyprogesterone acetate (MAP) and fluorogestone acetate (FGA) for synchronization found
no significant difference in estrous response and conception rate, concluding that the use of
CIDR, MAP and FGA treatments are equally efficient in synchronizing estrus in goats.
The multivariate model of this study found a strong association between superovulation
treatments and ovulation rates (p<0.0001), the total number of embryos collected (p<0.001), the
number of embryos of transferable quality (p=0.02), and the number of UFOs (p=0.05). The
post-ANOV A analysis found that the use of Ovagen alone or in association with PMSG induced
the production of significantly higher corpora lutea, eggs and transferable embryos than did the
use of Embryo-S, whether alone or in association with PMSG. Our study also interestingly
found that the addition of PMSG to Ovagen significantly increased the number of transferable
embryos and showed a non-significant decrease of UFOs (Table 6-4).
Similar comparative studies between the two superovulation agents (Ovagen vs. Embryo-S)
from the same source (ovine pituitary) have not been conducted, as far as we know, showing the
uniqueness of our study. However, many other studies consulted in the literature were
comparing the efficiency of superovulation agents from an ovine source with those from other
sources; porcine (FSH-P), equine (eCG), or human (hMG). One such investigation conducted in
India by Kumar et al. (2003) had the objective of comparing the efficacy of FSH-O (an ovine
FSH preparation, Ovagen) with FSH-P and eCG on superovulatory response in Tellicherry
goats. The result of that study demonstrated the effectiveness of FSH-O over the other agents in
regard to the ovulation rate, total embryo recovery and number of transferable embryos. The
higher ovulation rate seen in the FSH-O group compared with the FSH-P and eCG groups may
be due to the lower LH:FSH ratio in the FSH-O preparation than in the FSH-P and eCG
preparations (McNatty et al., 1989; Henderson et al., 1990). The study therefore recommended
FSH-O (Ovagen) as a gonadotropin of choice for superovulation of Tellicherry goats when
compared to FSH-P and eCG. We might also imply in our study comparing Ovagen and
Embryo-S that the advantage observed of Ovagen over Embryo-S in producing corpora lutea and
transferable embryos may be due to the high proportion of LH contained in the Embryo-S
preparation.
One other study, performed in Spain on the Murciano-Granadina goat by Gonzales-Bulnes et al.
(2003), found the mean ovulation rate in goats treated with purified ovine FSH (Ovagen) to be
higher than reported in the previous studies on the same breed using a single superovulatory
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dose of eCG or using several doses of porcine FSH or FSH in combination with eCG (pintado et
al., 1998). The same Spanish study resulted in a higher number of recovered and viable
embryos, compared to the previous one, confirming the advantages of using highly purified
gonadotropins (Cognie, 1999).
The benefit of the addition of PMSG to Ovagen, found in this study to significantly increase the
number of transferable embryos with a non-significant decrease of UFOs, might be explained in
Cognie's report on the state of the art in sheep-goat embryo transfer (Cognie, 1999). He reported
that even though highly purified FSH-O (Ovagen) and FSH-P (Folltropin) are efficient, a
minimum amount of LH is essential after the removal of progestagen (FSHlLH: 0.3-0.4 in the
last two injections, respectively) to increase the superovulatory responses and the number of
transferable embryos recovered (Cognie, 1999). LH contained in the PMSG added to the highly
purified Ovagen may have caused the increase found in our study.
Apart from synchronization (marginal effect) and superovulation treatments (significant effect),
the multivariate analysis did not show any significant effect by other factors (the use of ECP,
body condition, age) as a main effect. The effectiveness of the addition of estradiol cypionate
(ECP) was shown in its association (p=0.05) with better quality embryos in the univariate
analysis, although it did not have significance as a main effect in the multivariate model. These
results agree with many findings in cows attributing to the estrogen treatment the ability to cause
regression of ovarian follicles with emergence of new follicular wave (Mapletoft & Bo, 1994).
One using a synchronization program with 5MB and estradiol valerate concluded that estradiol
valerate induces atresia of the antral follicles in cows with 5MB implant. It thus seems possible
to synchronize, by inducing atresia of existing antral follicles, a new wave of follicular
development that would be responsive to the super-stimulatory treatments and therefore result in
more ovulations and higher ova/embryo quality (Mapletoft et al., 1994). There were no
significant effects by age and body condition in this design. A difference of season was
significant (p<0.05) in the univariate analysis on the number of transferable embryos and UFOs.
The number of transferable embryos was higher in the falVwinter season than spring/summer.
This is consistent with seasonality in the South African Boer does, which have a peak of sexual
activity during April and May (Fall / Autumn) and lowest sexual activity from October to
January (late Spring to mid-Summer) (Greyling, 1988). Our study also found the mean ovulation
rate of 10 in all does and 13 in does with CL :1 5. Compared to several findings reported by
Wallace, 1992 (Table 3-1), this rate is acceptable. Our recovery rate was 76.5%. This study
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also shows a generally higher number of CL on the left ovary (52%) than on the right ovary
(48%).
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